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ABSTRACT 
The purpose of this study was to identify factors contributing to non-compliance 
to TB treatment amongst pulmonary TB patients in Waterberg district, Limpopo. 
The health-belief model was the conceptual framework which guided this study. 
A quantitative, cross-sectional, descriptive study design was used. 
Data was collected using a structured questionnaire administered by trained data 
collectors. Data was collected from 215 respondents. Informed consent was 
obtained from each respondent prior to data collection. MS Excel and SPSS 
were used to analyse data. Findings on significant factors contributing to non-
compliance to TB treatment include; non-availability of food whilst taking TB 
treatment, disbelief in the fact that TB can result in death if not treated, belief in 
traditional medicine for curing TB, bad healthcare worker attitudes, long distance 
to the clinic for treatment, belief that TB treatment takes very long and the pill 
burden. 
Key Concepts: Non-compliance, Tuberculosis, health-belief model 
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CHAPTER 1: INTRODUCTION 
1.1 BACKGROUND TO THE STUDY 
Tuberculosis (TB) remains a major, worldwide, public-health problem in the 21st 
century (World Health Organisation (WHO), 2010:3). This disease is one of the 
leading causes of morbidity and mortality in South Africa, and its elimination 
remains a major challenge to the Department of Health (National Department of 
Health, 2009:9). Although there are treatment regimens that have a greater than 
95% efficacy in tuberculosis patients infected with mycobacterium tuberculosis 
strains susceptible to first line drugs, there are a number of patients who are 
unable to comply with treatment in some parts of Africa such as Uganda (13.0%), 
Nigeria (1 0.0%) and South Africa, with a non-compliance rate of 9.1% (Vieira and 
Ribera, 2011 :215-227). As a consequence of this, thousands of patients die from 
tuberculosis every year (WHO, 201 0:3). The emergence of drug resistant 
tuberculosis has compounded the situation, increasing the mortality rate to 40 
per 100 000 population (WHO, 201 0:4). 
Efforts to control the tuberculosis epidemic depend largely on patients' 
compliance to tuberculosis treatment (Setswe, 2009:3). Currently compliance to 
treatment amongst tuberculosis patients is poor in South Africa as evidenced by 
high defaulter rates of 12% (WHO, 2010:6). Factors related to non-compliance to 
tuberculosis treatment in South Africa are: healthcare system, therapy-related, 
social, and economic, as well as client-related factors (National Department of 
health, 2009:47). 
Efforts to improve compliance to tuberculosis treatment have been made by the 
South African TB control programme, which adopted a client-centred approach 
that enhances compliance by ensuring that TB services are convenient to the 
client, and were aimed at increasing the cure rate to 85% by 2011 (National 
Department of Health, 2009:11 ). 
1 
Despite this strategy, TB cure rates in South Africa remain below 85%.Kandel, 
Mfenyana, Chandia & Yogeswaran (2008:47) observe that three factors may 
contribute to non-compliance to TB treatment, these being poor communication 
between health care providers and patients, financial constraints limiting access 
to health care facilities and lack of nutritious food which supports TB treatment. 
The National Institute of Health (201 0:5) is of the view that illiteracy is the main 
factor in non-compliance to TB treatment, as clients may not understand written 
instructions about the treatment. Other researchers assert that TB may not be 
completely cured by scientific treatment and that patients will resort to alternate 
modes of treatment (Matebesi and Timmerman, 2006:2). The National Institute of 
Health (201 0:5) report states that substance abuse, being home-bound, stigma 
and lack of trust in Western medication all cause patients to be non-compliant to 
TB treatment. 
In the light of the high morbidity and non-compliance rates to pulmonary TB 
treatment, the South African National TB Control Programme (NTCP) adopted 
the World Health Organisation (WHO) strategy of Directly Observed Treatment 
Short Course (DOTS) in 1996. This approach encourages a support person to 
enhance compliance to TB treatment (WHO, 2011 b:27). The 'Stop TB strategy' 
states that compliance to TB treatment can be increased by using a patient-
centred approach to care and treatment delivery. It further emphasizes innovative 
measures designed to identify and address physical, financial, social and cultural 
obstacles that may contribute to non-compliance to TB treatment (WHO, 
2010:78). 
The aims of the 'Stop TB' and DOTS strategy are to increase the TB treatment 
success rate from 60% to 85% for all smear positive Pulmonary TB cases and to 
detect 70% of such cases (WHO, 2006-2015:32). The ultimate goal of the 'Stop 
TB' and DOTS strategy is to encourage family members to actively support 
patients and enhance compliance to TB treatment (WHO, report 201 0:5). 
2 
According to the South African National Department of Health (2009:48) and 
McKinney (201 0:1 ), a basic approach should be used in promoting compliance to 
TB treatment, such as: access to treatment; education on the benefits of 
complying with treatment; and rendering user-friendly services, that are culturally 
acceptable and convenient to patients. These factors are critical to TB treatment 
as the treatment of active tuberculosis involves taking multiple drugs daily for 8 
months (WHO, 2010:21). 
The standard treatment recommended by the South African National TB Control 
Programme as stated in the National Department of Health (2009:38), includes 
an initial drug combination of four drugs, namely Rifampicin, Isoniazid, 
Pyrazinamide and Ethambutol, which are administered daily through the 
intensive phase (2 months) and then two drugs (Rifampicin and Isoniazid) taken 
daily in the continuation phase (4 months). Non-compliant patients are given a 
five drug combination · (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol and 
Streptomycin) daily in the first 2 months, followed by a four-drug combination 
(Rifampicin, Isoniazid, Pyrazinamide and Ethambutol) for an additional month of 
the intensive phase and three drugs (Rifampicin, Isoniazid and Ethambutol) daily 
throughout the continuation phase (5 months). Compliance to treatment is 
critical in order to prevent the development of resistance to TB which will 
ultimately cause premature death (Rieder, 2002:11 ). 
In order to enhance compliance, the South African National Department of Health 
(2009:37) state that fixed dose combination drugs should be used in order to 
lessen the pill burden. Additionally, negative socio-cultural issues must be 
addressed (National Department of Health, 2009:37). Patient education should 
be strengthened (WHO, 2011 b:61) and TB services must be accessible, 
affordable and convenient to patients (National Department of Health, 2009:38). 
3 
The Department of Health is of the view that if more DOTS supporters are 
recruited, the non-compliance rate may be reduced to less than 5 % in 
Waterberg District. This approach is likely to improve the current non-
compliance rate of 13.2% in the District. Globally, tuberculosis (TB) is 
responsible for 5000 mortalities per day and more than 2.3 million per year 
(WHO, 2009:13). The global tuberculosis incident rates reported each year are 
above 9 million (WHO, 2009:13). This number is likely to increase as a result of 
TB/HIV co-infection (WHO, 2009:13). About 30% of the tuberculosis cases 
reported globally occur in Africa (WHO, International Labour Organisation (ILO) & 
United Nations Against AIDS (UNAIDS), 2010:2). Countries with the largest 
number of incidents of tuberculosis cases in Africa are South Africa (0.40-0.59 
million) and Nigeria (0.37-0.55 million) respectively (WHO Report, 2010: 5). 
South Africa has the highest TB incidence in the world, at over 5 times the 
average incidence rate found in 22 high-burden countries (WHO, 2010:5). The 
country has the fourth highest estimated total burden of TB incidence in the world 
compared to China (99/1 00 000), India (168/1 00 000) and Indonesia (234/1 00 
000), countries with much larger populations (WHO, 2010:6). In 2009, a total 
number of 405 982 TB cases were diagnosed and initiated on TB treatment in 
South Africa (National Department of Health 2011 :9). Pulmonary TB cases 
accounted for 84% of the total caseload and extra-pulmonary TB for 16% 
(National Department of Health, 2011 :9). The same report states that 7 343 MDR 
TB cases were reported in South Africa in the same year. Approximately 26 000 
people died from TB in 2009 in South Africa of whom 80% were pulmonary TB 
cases (WHO 2010:6). 
The National Department of Health (2010:9-10) reports that Limpopo Province 
contributed 5.4% (22 112) of the total TB cases that were initiated on treatment in 
South Africa in 2010. 
4 
Pulmonary TB cases accounted for 83% of the total cases and extra pulmonary 
TB for 17% (National Department of Health, 2010:9-1 0). The mortality rate 
among TB patients in 2010 was 9.2% (842) in Limpopo. In 2010, Waterberg was 
the second district with the highest number of TB cases enrolled on treatment in 
Limpopo (715), behind Capricorn District where a total of 883 cases were notified 
(National Department of Health, 2010:12). 
Although the treatment success rate in South Africa has increased from 62.9% in 
2000 to 76.0% in 2009, the treatment success rate in Waterberg district is 
currently at 68.0% (National Department of Health, 201 0:12). Furthermore, the 
non-compliance rate is high (13.2%), and consequently, TB mortality in 
Waterberg District is 8.4% (National Department of Health, 2010:13). 
1.2 PROBLEM STATEMENT 
Waterberg is the second district with the highest prevalence rate for TB in the 
Limpopo Province, contributing 20.5% (4 535) of the total TB cases enrolled for 
treatment in Limpopo province in 2010 (National Department of Health, 201 0:12). 
Non-compliance to tuberculosis (TB) treatment has a direct impact on cure rates 
which are currently below 85% amongst patients in Waterberg district (National 
Department of Health, 2010:9-1 0). 
Data from Department of Health regarding treatment outcomes reports that in 
Limpopo province in 2012 7.7% of the pulmonary TB patients were non-
compliant to treatment. Waterberg district had the highest non-compliance rate 
(13.2%) for pulmonary TB patients amongst the five districts in the province 
(National Department of Health, 2010:9-10). Mokgoadi (2002:3) notes that non-
compliance to TB treatment in Limpopo province resulted in poor social and 
economic outcomes for individuals, families and society. 
5 
It is from this perspective that the researcher conducted the study to determine 
patient-related factors and health-service factors responsible for non-compliance 
to pulmonary TB treatment among patients in public health institutions in 
Waterberg District. 
1.3 Research purpose 
The overall purpose of the study was to explore and describe the reasons why 
pulmonary TB patients were non-compliant to treatment in Waterberg District, 
Limpopo Province. 
1.4 Research objectives 
The specific objectives of this study are; 
1. To determine the compliance patterns among TB patients in Waterberg 
district; 
2. To assess the level of knowledge of TB patients in Waterberg District 
about TB treatment; 
3. To identify the socio-cultural factors responsible for non-compliance with 
TB treatment among the TB patients; 
4. To identify the health-related factors which may result in non-compliance 
to TB treatment among the respondents 
1.5 SIGNIFICANCE OF THE STUDY 
The study will contribute to the existing body of knowledge on compliance to TB 
treatment by providing insight into patient-related factors and health-service 
factors which result in non-compliance to TB treatment. The study will also 
contribute towards the development of strategies aimed at: 
• Increasing compliance to TB treatment; and 
• Decreasing the TB defaulter rates and patients lost to follow up. 
• Improve the general outcomes of TB patients 
6 
Findings generated from this study will assist the Limpopo Provincial Department 
of Health and Waterberg District to review their tuberculosis case holding policy 
and to influence healthcare workers to display positive therapeutic behavior of 
such as adherence counseling, support and care for patients on TB treatment. 
1.6 DEFINITION OF KEY CONCEPTS 
1.6.1 Compliance 
Compliance is the continuous, correct and uninterrupted taking of prescribed 
medication as directed by the healthcare professional (International Union 
Against TB and Lung Disease (IUATLD), 201 0:12). 
In this study, compliance will be defined as taking of tuberculosis medication 
daily at the right time, at a dosage in line with the TB treatment guidelines for 
about 8 months, with the correct diet and avoiding alcohol until the patient is 
declared cured by a health-care professional (Mokgoadi. 2002:18). 
1.6.2 DOTS 
DOTS is an internationally recognised strategy for delivering the basics of TB 
case-finding and cure. It is not simply a clinical approach to patients, but rather a 
management strategy for public health systems, including political commitment 
as well as case-detection through quality assured bacteriology, short-course 
chemotherapy, ensuring patient adherence to treatment, adequate drug supply 
and sound reporting and recording systems (WHO, 2006-2015:32). 
1.6.3 DOTS supporter 
A DOTS supporter is a community healthcare worker who is trained on TB 
management and directly observes a TB patient daily whenever the patient is 
taking the prescribed TB treatment, until she or he has completed the course of 
treatment (WHO, 2004:9). 
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The DOTS supporter also provides ongoing counseling on compliance to TB 
treatment and further advice on management of minor side effects at community 
level (WHO, 2004:9). 
1.6.4 Factors 
Factors are client or health-system related elements which contribute to a certain 
result (non-compliance to TB treatment) (WHO, 2004:27). 
1.6.5 First-Line TB drugs 
First-Line TB drugs are the drugs used in the treatment of susceptible TB (WHO, 
2010:11) and for this study they will be Rifampicin, Isoniazid, Pyrazinamide, 
Ethambutol and Streptomycin, which are recommended by the Department of 
Health in South Africa in line with WHO recommendations (National Department 
of Health, 2009:36). 
1.6.6 Non-Compliance 
Non-compliance refers to the interruption of tuberculosis treatment or missing 
doses during the course of treatment (Swaziland Ministry of Health, 2006:49). 
In this study non-compliance will be defined as not taking tuberculosis treatment 
daily for the prescribed duration in accordance with the TB treatment guidelines. 
This includes patients who miss any dose(s) of the TB treatment for whatever 
reason. 
1.6. 7 Patients 
Patients are individuals diagnosed with pulmonary TB and who have been 
initiated on TB treatment for more than 2 months (Swaziland Ministry of Health, 
2006:61 ). In this study patients are individuals aged 18-49, diagnosed with 
pulmonary TB, who have been initiated on TB treatment for 2 months or more. 
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1.6.8 Pulmonary TB 
Pulmonary TB refers to tuberculosis involving only the lung parenchyma (WHO, 
201 0:24). Pulmonary TB cases are classified as smear-positive if sputum 
specimens are positive for acid-fast bacilli, smear-negative if sputum specimens 
are negative for acid-fast bacilli and smear not done if other diagnostic measures 
apart from smears were used (Swaziland Ministry of Health, 2006:22). The most 
common pulmonary TB in South Africa and Waterberg District is smear-positive 
TB (National Department of Health, 2010:5). 
1.6.9 Second Line TB Drugs 
These are drugs used in the treatment of resistant, non-susceptible TB or for 
non-compliant patients who have resumed TB treatment (National Department of 
Health, 2011 :26). These drugs are not widely available in less-resourced 
countries, they are less effective and more toxic than first line drugs. They 
include ethionamide, kanamycin, capreomycin, amikacin, ofloxacin, moxifloxacin, 
levofloxacin, protionamide, cycloserine, terizidone, p-aminosalicylic acid, 
amoxicillin/clavulanate and clarithromycin (WHO, 2010:11 ). 
In South Africa the second-line management of TB includes a combination of 
kanamycin, ofloxacin, ethionamide, terizidone or cycloserine and pyrazinamide 
for the 6-month intensive phase. This is followed by an 18 month continuation 
phase using ofloxacin, ethionamide, terizidone or cycloserine and pyrazinamide 
(National Department of Health, 2008:17). 
1.6.1 0 Tuberculosis (TB) 
Tuberculosis is an infectious disease caused by mycobacterium tuberculosis that 
is spread from an infected person through the air when he or she coughs, 
sneezes or talk. It can attack other parts of the body like the bones, kidneys and 
spine (IUATLD, 2010:5). 
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For this research, tuberculosis will refer to pulmonary tuberculosis (affecting the 
lungs) which has been diagnosed by a health provider who has initiated 
treatment for two months. 
1.6.11 Waterberg District 
Waterberg is one of the 5 districts of the Limpopo Province of South Africa. It 
consists of 6 sub-districts namely: Mogalakwena; Modimolle; Mokgoophong; 
Thabazimbi; Bela Bela; and Lephalale. The majority of its 614 139 people speak 
Northern Sotho and Sepedi (Waterberg District Municipality, 2011:1 ). TB is very 
prevalent in this District due to factors such as poverty, alcoholism and exposure 
to pollutants for miners who form a huge proportion of the employed population in 
the District (Waterberg District Municipality, 2011:1 ). 
1.7 VALIDITY AND RELIABILITY 
1.7.1 Validity 
According to Campbell & Stanley (2006: 67), internal validity refers to how well a 
study was run (research design, operational definitions used, how variables were 
measured, what was or was not measured), and how confidently one can 
conclude that the observed effects were produced solely by the independent 
variable and not extraneous ones. 
Internal validity was enhanced by using the cross sectional survey which is the 
most appropriate design for the study purpose and a data collection tool that was 
deemed objective and valid. A pre-test was initially administered and 
respondents who participated in the pre-test were not included in the study. Also, 
compliance to the study protocol was strictly observed and data collectors were 
individuals who were not exposed in the study area (Ghani, 201 0:54). 
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Campbell & Stanley (2006:67) indicate that external validity represents the extent 
to which a study's results can be generalised or applied to other people or 
settings. In this study external validity was enhanced by including respondents 
from various facilities in Waterberg to increase the possibility of genera/ising 
findings and ensuring equal inclusion of all ages in the 18-49 years range. 
1. 7.2 Reliability 
According to Polit & Hungler (1997:467), reliability of a data collection instrument 
refers to the degree of consistency or dependability with which it measures the 
attribute it is designed to measure. To enhance reliability of the questionnaire, a 
pre-test of the tool was conducted. The pre-test identified areas of ambiguity in 
the questionnaire for example the questions on how far do you travel to collect 
your TB medicines (Km) and distance from nearest health care facility (Km) gave 
identical responses hence one of the questions was omitted. All other questions 
were clear and understandable to respondents. 
1.8 ETHICAL CONSIDERATIONS 
According to Stommel & Wills (2004:373), ethics is an academic discipline based 
in the philosophic and social sciences that is concerned with descriptive and 
prescriptive questions of morality. 
The ethical principles as set out below were observed in this study. 
1.8.1 Protecting the rights of the participants 
1.8. 1.1 Right to full disclosure and informed consent 
Participants were given an informed consent form explaining the details of the 
study after adequate, truthful and accurate information (veracity) about the study 
was provided (Burns & Grove 2005:194). 
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For illiterate participants the consent form was read out to them in Sepedi (the 
local language). To indicate consent, illiterate participants were given a thumb 
print whilst literate participants were requested to sign the consent form as 
advised by Tshabalala (2007:50). 
1.8.1.2 Right to autonomy 
Participants were not pressured to participate in the study but participated 
voluntarily, thus exercising autonomy (Burns & Grove 2005:189). 
1.8.1.3 Right not to be harmed in any manner (physically, psychologically or 
emotionally) 
This study ensured that participants were protected from physical, psychological 
or emotional harm (Burns & Grove 2005:176). 
1.8.2 Protecting the rights of the institution 
Approval to conduct the study was obtained from the Higher Degree Committee 
of the Department of Health Studies, University of South Africa. Permission to 
conduct the study was granted by the Limpopo Department of Health and 
relevant District managers (Burns & Grove, 2005:193). 
1.8.2. 1 Scientific integrity of the research 
To promote scientific integrity, information obtained from other publications as 
well as other sources was acknowledged in the references (Burns & Grove, 
2005:193), results were not be fabricated, research materials and processes 
were not manipulated and data or results were not omitted when reporting the 
study findings (Macrina, 2005:1). 
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1.8.2.2 Relationship to society (Accountability) 
This study was conducted in public and its findings will be reported in a full, open 
and timely fashion to the scientific community (Babbie & Mouton, 2005:521). 
Participants were informed before consenting to participate in the study that 
results of the study will be shared with the scientific community (Babbie & 
Mouton, 2005:522). 
1.9 SCOPE AND LIMITATIONS OF THE STUDY 
Measurement errors may occur in reporting issues around non-compliance to 
tuberculosis treatment due to the grant received by tuberculosis patients which 
on its own may affect compliance to treatment amongst patients, yet they will not 
openly give out such information (Mokgoadi, 2002:37). There is no reliable 
method for measuring compliance to TB treatment in primary health care clinics 
in South Africa (Nyambura, 2009:8). The scope of the study was limited to adults 
aged 18-49 years, hence views for children and the elderly were not captured 
(Nyambura, 2009:7). 
Another limitation of the study was that the target population were patients who 
were receiving treatment for at least 2 months thus views for newly initiated TB 
patients were not captured (Abdul & Guluza, 2009:70). These inclusion and 
exclusion criteria restricted the population to which findings can be generalised 
(Burns & Grove, 2005:40). 
Questions in the questionnaire were written in English but translated to Sepedi 
during data collection, which could result in inconsistency in the way the 
questionnaire was administered as some important facts, could be lost in the 
translation (Burns & Grove, 2005:402). The study cannot be entirely generalised 
due to the small non-probability sample that was used. 
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Additionally a cross sectional design may not yield rich data that can be 
extrapolated on a longitudinal study (Stommel & Wills, 2004: 391 ). More detail on 
the limitations will be discussed in detail in Chapter 3. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 DATA BASED LITERATURE 
2.1.1 INTRODUCTION 
This Chapter discusses the literature review conducted by the researcher in 
keeping with the aims of this study, namely to identify factors contributing to non-
compliance to TB treatment in Waterberg District in Limpopo Province. The 
chapter reviews relevant literature from previous studies on factors associated 
with or contributing to TB treatment compliance or non-compliance. The scope of 
the literature review, therefore, is to synthesize evidence from textbooks, 
published and unpublished research, scientific reports and other credible sources 
of scientific work done globally, mainly on TB treatment compliance issues. 
Several sources were consulted, including medical and research textbooks, the 
latest relevant journals, WHO publications, district reports, the internet and 
several Department of Health (DoH) publications. Internet search engines used 
included google and yahoo. 
2.1.2 TB STATUS IN SOUTH AFRICA 
The TB epidemic in South Africa remains one of the major healthcare challenges 
as stated by the National Department of Health (2009: 1) report. Data from the 
World Health Organisation (2005:13) reports that South Africa is among 
countries with the highest TB infection rates. In retrospect, the National 
Department of Health points out that approximately 60% of South Africans carry 
the TB bacilli in their bodies. As such, it was further indicated that the country 
ranks fourth out of twenty-two countries that are hardest hit by TB at the global 
level (WHO, 2005:19). 
The disease rates are more than twice those recorded in other developing 
nations and 60% higher than those recorded in Europe (Fourie, 2006:91). 
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On a yearly basis, South Africa reports more than 400 000 cases of TB, yielding 
an incidence rate of more than 800/100 000 of the population (National 
Department of Health, 2010:17).This is a tremendous increase in the incidence 
from 301/100 000 population reported in 1990. According to the WHO (2011 :39), 
a total of 400 391 TB cases were initiated on treatment in South Africa in 201 0. 
Of these 354 241 were pulmonary TB cases. About 45% of the pulmonary TB 
cases were smear-positive (WHO, 2011 :39). 
Despite an increase in the proportion of new pulmonary smear-positive TB cases 
completing TB treatment, the treatment success rate in South Africa is currently 
at 76% which falls short of the WHO target of 85% (WHO, 2011 :23). The non-
compliance rate amongst new pulmonary smear-positive TB cases is 7%, and 
12% of the pulmonary TB cases are not easily traced due to socio-economic 
challenges and are not evaluated during or after administration of treatment 
(WHO, 2011 :23). 
2.1.31NITIATION INTO TB THERAPY 
According to the National Department of Health (2000:12), all patients who 
present with any of the following symptoms are investigated for TB: 
• Persistent cough for two weeks or more; 
• Sputum production which may be blood stained; 
• Shortness of breath and chest pains; 
• Loss of both appetite and weight; 
• Fatigue; and 
• Night sweats and fever. 
South Africa complies with the World Health Organisation (WHO) guidelines for 
diagnosing and treating tuberculosis. Two sputum specimens are collected from 
each TB suspect. 
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The first specimen is collected on the spot at the first encounter with the patient 
and the second specimen is collected early in the morning the following day. The 
patient's personal particulars coupled with the date of dispatch of the specimens 
to the laboratory are captured in the TB suspect register also known as the TB-
case identification register. Under normal circumstances, sputum results are 
available within 48 hours and TB treatment should be initiated as soon as 
positive sputum results are reported (National Department of Health, 2009:36). 
In South Africa, TB treatment initiation is decentralised from hospitals and 
community health centres to primary health-care facilities. The benefit of this 
approach is to increase access to TB treatment and ensure timely initiation of 
smear-positive TB cases onto treatment (Tshabalala, 2007:21 ). Initiation of TB 
treatment in South Africa is offered by both doctors and nurses on all TB smear-
positive patients (Tshabalala, 2007:25). According to the National Department of 
Health (2000:28), TB treatment is categorised into four regimens namely: 
• Regimen I for new cases aged eight years and above; 
• Regimen II for retreatrnent cases; 
• Regimen Ill for children below eight years; and 
• Regimen IV for MDR TB cases. 
The standard treatment regimen for a new pulmonary TB case aged eight years 
and above includes four drugs, these being rifampicin, isoniazid, pyrazinamide 
and ethambutol, in the first 2 months known as the intensive phase. Following 
the intensive phase, a combination of two drugs, rifampicin and isoniazid, is 
given to patient for four months (National Department of Health, 2009:36). This 
makes the treatment duration for new cases six months. According to the 
National Department of Health (2009:37), the regimen for retreatrnent cases 
includes five drugs (rifampicin, isoniazid, pyrazinamide, ethambutol and 
streptomycin) in the first two months. 
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This is followed by a third month of the intensive phase consisting of four drugs, 
rifampicin, isoniazid, pyrazinamide and ethambutol. The three month intensive 
phase is then followed by a five-month continuation phase consisting of three 
drugs, rifampicin, isoniazid and ethambutol. 
2.1.4 COMPLIANCE TO TB TREATMENT 
Compliance to TB treatment refers to taking tuberculosis medication daily at the 
right time, in dosages in line with the TB treatment guidelines for 6 months until 
the patient is declared cured by a healthcare professional (Mokgoadi, 2002:18). 
The Free Dictionary (201 0:2) defines compliance as the degree or extent to 
which a patient follows or completes a prescribed regimen of treatment. Gandhi 
(201 0:2) states that compliance can be defined as the extent to which a patient's 
behaviour coincides with medical advice. It captures the increasing complexity of 
TB chemotherapy by characterising patients as independent, intelligent and 
autonomous people who take active and voluntary roles in defining and pursuing 
goals for their medical treatment (Gandhi, 201 0:2). 
According to the WHO (2010:78), locally appropriate measures should be taken 
to identify and address physical, financial, social and cultural obstacles that can 
result in non-compliance to TB treatment. To ensure compliance to TB treatment, 
South Africa adopted the DOTS strategy in 1996 (National Department of Health, 
201 0:19). Components of this strategy directly linked to improving compliance to 
TB treatment include the direct observation of treatment (DOT) and ensuring an 
uninterrupted drug supply (WHO, 2011 b:27). 
According to Tshabalala (2007:29), DOT which involves observing the patient 
swallow the TB drugs is one of the main strategies for increasing compliance to 
TB treatment. The National TB Guidelines (2009:48) state that DOT should be 
provided to all TB patients throughout the treatment period and also that the 
approach to applying DOT should be flexible and suit the patient's needs. 
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In South Africa, there are three types of DOT provided to TB patients, these 
include: 
Clinic-based DOT: In this strategy TB patients residing close to health facilities 
are encouraged to be observed by facility staff on a daily basis when taking their 
treatment (National Department of Health, 2009:48). In this strategy, healthcare 
workers provide on-going care and counselling to patients about the benefits of 
compliance to TB treatment, however, the clinic DOT strategy is generally 
inaccessible, inconvenient, costly and unaffordable to the majority of clients due 
to geographical location and socio-economic challenges (National Department of 
Health, 2009:48). 
Workplace DOT: involves the observation of treatment in the workplace to 
increase compliance to TB treatment for patients who have challenges in 
accessing health care facilities due to their busy work schedules (WHO, 
2011 b:62). The benefit of this strategy to employees is access to treatment 
support and avoids absenteeism which may have a detrimental outcome to 
patients' economic status (National Department of Health, 2009:48). 
Community-based DOT involves daily observation of the TB patient taking 
treatment at his or her home (WHO, 2011 b: 62). According to the National 
Department of Health (2009:49), the community-based DOT contributes 
substantially to increasing compliance to TB treatment, because it is accessible 
to clients. (National Department of Health, 2009:49). The only challenge with this 
strategy is to define the level of accountability for its users, as trained support 
people are ideal in order to monitor and support patients in adherence to 
treatment and report to relevant health authorities as the need may arise 
(National Department of Health, 2009:49). 
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2.1.5 NON-COMPLIANCE LEVELS 
Compliance to TB treatment is measured by evaluating the treatment success 
rate which should be above 85%. Non-compliance rate is defined as the 
proportion of TB patients who fail to follow instructions, particularly in 
administering TB medication as prescribed, a cause of a less than expected 
response to treatment (Free Dictionary 201 0:2). This rate should be less than 5% 
(WHO, 2008:6). Non-compliance to TB treatment has a direct impact on cure 
rates, and currently data reports that the TB cure rate is 69% for South Africa 
(WHO, 2011 :23). 
This is far below the WHO target for cure rate which is 85%. Data on TB 
treatment outcomes indicates that in the year 2010, 7% of the pulmonary TB 
patients in South Africa were non-compliant to treatment (WHO, 2011 :23). 
Waterberg District in Limpopo Province recorded the highest non-compliance 
rate of 13.2% for pulmonary TB patients of all the five districts in the province 
(National Department of Health, 2010:9-10). 
Harrison (2001 :76) indicates that non-compliance to treatment is the most 
important impediment to cure. Patients who do not comply with the prescribed 
treatment regimen are reported to have a higher probability of developing 
Acquired Drug Resistance (ADR). Gandhi (2010:5) states that non-compliance 
with TB treatment is a major problem that leads to treatment failure, relapses and 
emergence of drug resistance. This exposes both the patient and the community 
to grave danger. Although ADR rates are not currently reported in South Africa, 
the drug resistance rate is 6.9% in Limpopo Province (National Department of 
Health, 2010:12). 
Non-compliance to TB treatment prolongs morbidity and community members 
become vulnerable to TB because clients/patients remain infectious for a much 
longer period than would be the case if they were compliant (Petrie, 2005:4). 
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The main contributing factor to non-compliance (Motlhake, 2005: 18) is the long-
term treatment (usually six months) to intensively 'clean up' TB infection in the 
system. This view is supported by Noback and Corolla (2005:7). Pandit & 
Chowdary (2002:67) also concur with this view and further state that toxicity of 
TB drugs is one of the major reasons for non-compliance to TB treatment. 
The benefits of compliance to TB therapy (Mhlophe, 2002:17) include total cure 
of the current infection and preventing new infection and the occurrence of multi-
drug resistant TB. At a social level, compliance to TB treatment normally results 
in positive treatment outcomes which ultimately leads to peace of mind and 
freedom among patients and their family members (IUATLD, 2010:26). The 
IUATLD, (2010:27) also indicates that compliance to TB treatment enables health 
workers to focus on other primary health care priorities by reducing the burden 
on national TB programs. This ultimately leads to a reduction in TB morbidity and 
mortality (WHO, 2000:4; Petrie, 2005:4; IUATLD, 201 0:90). 
2.1.6 FACTORS AFFECTING COMPLIANCE TO TB TREATMENT 
In the healthcare context, compliance refers to the extent to which patient 
behaviour coincides with medical advice (Giatthaar, 2003:118). A range of 
factors leading to TB treatment compliance or non-compliance by patients 
includes demographic, health-service, client-related, social and economic factors. 
Several authors (WHO, 2003:19; Shyrock, 2007:631) have explored some of the 
factors contributing to non-compliance, these being, age, educational status, 
family support, gender, marital status, access to health services, staff attitudes, 
patient-provider relationships, cultural beliefs, poverty and socio-economic 
status, patient knowledge on TB, stigma and discrimination and co-morbidities. 
These factors will be explored in this review. 
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2.1.6.1 Demographic factors 
Chaulet (2003:23) states that demographic factors are likely to cause non-
compliance to TB treatment. A study conducted by Estifanos & Bernt (2007:3) 
identifies demographic factors associated with non-compliance to TB treatment, 
which include the factors as set out below. 
2.1.6.1.1 Age 
Patients aged 25 years or older are more likely to be compliant compared to the 
other age groups (Estifanos & Bernt 2007:3). Although Volmink & Garner 
(2007:315) argue that there is no significant difference in the compliance patterns 
of patients of different ages, Shyrock (2007:632) concurs with Estifanos & Bernt 
(2007:3) that TB patients above 25 years old are more compliant to TB treatment 
than those below that age. Findings from a study conducted by Kaona, Tuba, 
Siziya & Sikaona (2004:68) state that age is not significantly associated with 
compliance to TB treatment 
2.1.6.1.2 Educational status 
The study conducted by Malik & Ahmad (2009:17) indicates that with regard to 
educational status, 55% of non-compliant TB patients were illiterate, 35% had 
passed primary school, 7% had passed secondary school and 3% were higher 
education graduates. Ghani (201 0:25) states that in a study carried out in 
Thailand aimed at determining the patient factors predicting successful 
treatment, out of 1 ,241 patients studied, 81% with higher educational levels and 
knowledge of tuberculosis were successfully treated, the argument being that 
these factors are associated with better compliance to TB treatment and 
subsequently treatment success (Okanurak, Kitayaporn & Akarasewi, 
2008:1162). 
22 
A study conducted by Gad eta/. (1997: 244-250) indicates that patients with low 
educational levels can have a poor treatment outcome as they may not read or 
understand written instructions with regard to TB treatment. 
2.1.6.1.3 Support by family 
There has been no documented evidence that support by family significantly 
increases compliance to TB treatment. Volmink & Garner (2007:317) indicate 
that the difference in compliance between patients who are supported by their 
families and those who are not is not statistically significant. 
2. 1. 6. 1.4 Gender and marital status 
Gender and marital status have also been explored and are strongly believed to 
have an influence on the degree of compliance to TB Treatment. From the study 
conducted by Malik & Ahmad (2009:16), out of 100 non-compliant TB patients 
surveyed, 63% were males and 37% were females. From the same study, out of 
the 1 00 non-compliant TB patients, 72% were married and 28% unmarried. 
2.1.6.2 Perceived barriers to action 
Perceived barriers to action as discussed in this review include health-service, 
client-related and social factors. 
2. 1. 6.2. 1 Health service factors 
A study by the IUATLD (2002:12) states that factors affecting compliance to TB 
treatment include health service factors such as TB treatment duration, access to 
treatment, staff attitudes and patient-provider relationships. 
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i) TB treatment 
Smetherman (2000:2) indicates that patients do not comply with treatment 
because tablets are taken for too long. According to Stanhope and Lancaster 
(2006:776), one of the biggest problems with compliance to TB treatment is the 
required lengthy therapy using multiple drug combinations. This on its own 
reduces patients' compliance to treatment. Clark {2009:793) indicates that failure 
to comply with the prescribed TB therapy results in treatment failure and the 
development of drug resistance. A study conducted by Mokgoadi (2002:42) finds 
that TB treatment is still perceived by the majority of patients as long, agonising 
and cumbersome, and there are still some doubts as to whether the disease is 
curable. 
ii) Access to TB treatment 
Findings from a study conducted by Kaona et at. (2004:68) reflect that poor 
access to a health care facility may have an effect on compliance to TB treatment 
as healthcare services may be inaccessible to patients. It further states that TB 
patients residing in remote areas with poor road infrastructure may be unable to 
visit health care facilities to access any form of treatment. 
Erhabor, Aghanwa, Yusuph, Adebayo, Arogundande & Omidiora (2000:235) 
concur with Estifanos & Bernt (2007:3) in stating that the distance from the TB 
patient's residence to the clinic has a direct relationship with the rate of 
compliance. The longer the distance, the poor the compliance to TB treatment. 
Erhabor et at. (2000:235) further state that compliance to TB treatment is found 
to be higher in those patients who live within 25km of the clinic compared to 
patients who live more than 25 km away. 
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In a study by Ghani (201 0:31 ), location of health outlet at 20km or more was 
found to cause an increase in non-compliance to TB treatment due to travelling 
constraints. The WHO (201 0:23) states that 7% of TB patients were non-
compliant to treatment in South Africa in 2009 due to several factors which 
among others include transport availability and proximity to healthcare sites. 
iii) Staff attitudes 
Negative staff attitudes have been associated with TB patients interrupting TB 
treatment (Ghani, 2010:31 ). A study by Mokgoadi (2002:39) suggests that a 
preventative measure to decrease non-compliance to TB treatment is to improve 
the attitude of health-care workers dealing with TB patients. 
iv) Patient-provider relationship 
A number of studies have shown the importance of the relationship between 
healthcare workers and their patients as a contributor to treatment compliance or 
non-compliance (Ghani, 2010: 31). A South African study (Peltzer, Onya, Seoka, 
Tladi & Malima 2002:67) establishes that the quality of healthcare provider and 
patient communication, coupled with correct causative belief, is associated with 
TB treatment compliance. The provider-related factors that promote compliance 
include education and support to the patient in the form of accessibility to health 
services and the utilisation of DOT and effective communication between the 
patient and healthcare providers {Giatthaar, 2003:206). 
2.1.6.2.2 Client-related factors 
i) Cultural beliefs 
Kobe (2006:32) states that non-compliance of most TB patients with prescribed 
treatment is caused, to a large extent, by cultural beliefs. Following that finding, 
the National Department of Health (2004:7) points out that traditional healers 
should work in collaboration with health professionals to prevent non-compliance 
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to prescribed TB treatment. Dyk (2001: 126) supports this view by emphasising 
that no TB prevention programme can succeed in Africa without the input of 
traditional healers. The idea behind the orthodox view is that traditional healers 
are regarded as effective agents of change since they function like social 
counsellors. 
They are regarded as guardians of the traditional code of morality and values. 
Adding to the same view, Dyk (2001 :126) further indicates that approximately 
80% of people in Africa rely on traditional medicine for most of their health needs. 
Overall, traditional healers are observed to have more influence in communities 
than health care professionals, hence the reason why it is beneficial to 
incorporate them into the treatment processes. 
A study conducted by Tshabalala (2007:39), in Tintswalo, Limpopo Province, and 
a study by Edington (1997b:279-943) find that some patients believe that TB is a 
punishment for breaking sexual rules such as sleeping with a widow or 
abstinence. As such, healthcare workers find it difficult to convince patients to 
comply with TB treatment as required, because their beliefs make them non-
compliant to treatment. 
ii) Poverty and socioeconomic status 
From an economic perspective the length of time and costs involved from TB 
diagnosis to subsequent treatment determines the degree of compliance and 
successful completion of the prescribed therapy. As a result, a proportion of 
patients, particularly the poor, may drop out completely at any stage of the 
process towards successful TB treatment (Kamolratanakul, 2009: 576). 
According to the WHO (2003:1), TB affects the most productive and 
economically active segment of the population and to a greater extent non-
compliance to TB treatment is higher among lower social class group. 
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A study in India by Pandit et a/. (2002:242), however does not find socio-
economic status to be significantly associated with TB treatment compliance. 
A study conducted by Tshabalala (2007:34) finds that poverty is a leading factor 
that results to TB patients' non- compliance to treatment. According Glatthaar 
(2003:207), the level of poverty influences compliance to TB treatment. Poor TB 
patients experience barriers to access for effective TB healthcare services, which 
can lead to non-compliance to treatment. Poverty is a barrier for patients to 
access services that improve health, such as food, water, sanitation and 
healthcare services (Giatthaar 2003:207). A study conducted by Malik & Ahmad 
(2009: 17) indicates that 67% of non-compliant TB patients were of lower social 
class, 28% from the middle and 5% from higher classes. 
iii) Knowledge of TB 
Gad et a/. (1997:244-250) states that compliance with TB treatment is 
significantly higher among patients who have a good knowledge of TB. Patients 
who know about the natural history of TB, its complications and the importance of 
complying with treatment exhibit improved compliance to TB treatment. Another 
study by Kaona et a!. (2004:68) reveals that compliance with TB treatment is 
significantly higher among patients who have good knowledge about TB 
compared to patients who do not. In a similar study in India in 1992, the authors 
found that there was an association between the compliance behaviour of TB 
patients and their knowledge of specific aspects of the disease. 
2.1.6.2.3 Social factors 
i) Stigma and discrimination 
Ghani (201 0:34) states that the presence or perceived presence of stigma and 
discrimination in a community may act as barriers to patients disclosing their 
disease to family or community members, who may provide much needed 
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psychosocial support to the patient (Eastwood & Hill, 2004:70). A study by 
Hodgson, Desclaux & Mukasa (2004:1281-1283) concludes that stigma and 
discrimination towards TB and HIV patients results in patients delaying seeking 
testing and treatment and thus poorer health outcomes. 
ii) Co-morbidities 
According to Ghani (2010:35) while there is no doubt that HIV predisposes an 
individual to developing TB, there is no consensus on whether HIV is associated 
with poor TB treatment compliance (WHO, 2002:2). However, possibilities of 
increased pill burden if the patient is on Anti-Retroviral Treatment (ART), 
increases incidences of side effects and other co-morbid conditions which result 
from HIV, such as depression and dementia, and may increase the likelihood of 
poor compliance to TB treatment. A similar study conducted in Namibia in 2006 
also revealed that patients who are receiving other treatments in addition to TB 
treatment are less compliant to TB treatment compared to patients who are only 
on TB treatment. 
2.1.6.3 Perceived severity of ill-health condition 
Factors discussed in this review with regard to perceived severity of ill-health 
condition, include patients not acknowledging the dangers of not completing TB 
treatment because of subsiding TB symptoms or feeling better. 
2.1.6.3.1 Subsiding TB symptoms or feeling better 
According to Ghani (201 0:28) patients might not see the need to continue with 
TB treatment when they are feeling better or well after taking the treatment for a 
while, usually 2 months out of the 6 months required treatment duration. 
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Ghani (201 0:28) also states that in a Nepal cross-sectional study of 130 
compliant and 25 non-compliant TB patients, 48% of the latter were more likely to 
think that they could stop TB treatment once they were free of symptoms and 
feeling well, because they thought they were cured (Bam, Chand & Shrestha, 
2005:51). 
O'Boyle eta!. (2002:307) & Kaona eta!. (2004:68) state that studies conducted in 
Zambia and Malawi showed that non-compliance was associated with being free 
of symptoms and that patients' defaulting behaviour occurs when TB symptoms 
disappear and they feel well, usually after a few months of TB treatment, 
forgetting the dangers of not completing TB treatment. 
2.1.7 MEASURING COMPLIANCE 
According to the National Department of Health (2005:1 09), compliance is a very 
important tool used in the assessment of effectiveness and success of treatment. 
It helps in monitoring changes in health outcomes based on the recommended 
treatment regimen. However, there is no gold standard that exists for measuring 
treatment compliance. Several different direct and indirect indicators have been 
used with varying success (National Department of Health, 2005:109). 
Direct measures of compliance include direct observation of medication taking, 
measuring levels of the drug or tracer compounds in body fluids, biological 
markers and monitoring clinic attendance (WHO, 2000:77). Direct observation of 
patients involves trained healthcare providers observing and recording the 
patient's compliance. The frequently used indirect measures include self-report of 
medication taking, monitoring of clinic attendance and pills, computation of 
medication refill rate, physician assessment and electronic monitoring for 
expected therapeutic outcome (National Department of Health, 2005:11 0). 
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Compliance to TB treatment means following the recommended course of 
treatment by taking all the prescribed medication for the entire length of time 
necessary (IUATLD, 2010:27). According to the National Department of Health 
(2004:38), the public principal health priority of the National TB Control 
Programme (NTCP) is to cure smear-positive cases, while preventing the 
emergence of drug resistant ones. 
The disease is effectively curable if patients are given and correctly take a 
complete an uninterrupted course of prescribed drug therapy. Any poor 
compliance measured by missing 5 doses or more per month of the prescribed 
medication, results in inadequate treatment as well as drug resistance (WHO, 
2000:77). According to the National Department of Health (2004:63), tuberculosis 
is a complex disease that carries biological, social, economic, and cultural 
ramifications for the patient, hence non-compliance by patients is a key factor 
leading to treatment failure. 
In order to measure compliance to TB treatment, the effectively implemented 
strategy recommended by the WHO is the Directly Observed Treatment (DOT) 
strategy. DOT means that an observer watches the patient swallowing the tablets 
in the way that is sensitive and supportive to the patients' needs. This ensures 
that a TB patient takes the right drug, in the right doses, at the right interval of 
time and for the right duration (WHO, 2000:78). 
According to the WHO (2011 :27) in DOTS programmes, almost twice as many 
patients successfully complete their treatment as compared to those in non-
DOTS programmes. The cure rates for TB patients in DOTS programmes are 
consistently high, even in countries which vary considerably in terms of culture, 
geography and socio-economic conditions. In South Africa, implementation of the 
DOTS programme resulted in cure rates rising up to over 70%. 
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Under the DOTS treatment approach, most patients can avoid costly hospital-
based treatment and can be treated whilst staying at home (WHO, 2011 :28). 
2.2 THEORETICAUCONCEPTUAL BASED LITERATURE 
2.2.1 THEORETICAL FOUNDATION OF THE STUDY 
2.2.1.1 Conceptual Framework 
The Health Belief Model (HBM) was identified as the conceptual framework for 
this study. The HBM was developed in the early 1950s, for addressing problem 
behaviours that evoke health concerns which include examining compliance to 
TB treatment (Marriner & Raile, 2005:63). 
Based on this model, the framework for this study was developed on the theory 
that personal beliefs influence health behaviour (Ali, 2002:31 ). This framework is 
based on selected components of the health belief model, namely perceived 
benefits of action, perceived barriers to action and perceived severity of ill health 
condition (Rosenstock, Strecher & Becker, 2004:5-24). Other constructs of the 
health belief model include perceived seriousness and perceived susceptibility. 
The study focused on the following concepts of the Health Belief Model as set 
out below. 
2.2. 1. 1. 1 Perceived seriousness or severity 
The construct of perceived seriousness speaks to an individual's belief about the 
seriousness or severity of a disease (Rosenstock, Strecher & Becker, 2004:5-
25). According to the United States Department of Health and Human Services 
(2000:213), while the perception of seriousness is often based on medical 
information and knowledge, it may also come from beliefs a person has about the 
difficulties a disease would create or the effects it would have on his or her life in 
general. 
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This study will determine the seriousness of failing to comply to TB treatment 
through evaluating participants' knowledge on what the consequences of not 
completing TB treatment are. 
2.2. 1. 1.2 Perceived susceptibility 
According to Marriner and Raile (2005:63) perceived susceptibility refers to a 
person's perception that a health problem is personally relevant or that the 
diagnosis of an illness is accurate. To determine perceived susceptibility in this 
study, participants will be asked whether they believe that they are suffering from 
TB and whether they believe that the diagnostic method used was accurate. 
2.2.1.1.3 Perceived benefits 
The construct of perceived benefits on the other hand is a person's opinion of the 
value or usefulness of a new behaviour in decreasing the risk of developing a 
disease (Ali, 2002:35}. According to Turner, Hunt, DiBrezzo & Jones (2004:115-
121 ), people tend to adopt healthier behaviours when they believe that the new 
behaviour will decrease their chances of developing a disease. In this study 
compliance may be attained if TB patients believe that they will gain health by 
taking the recommended treatment. 
2.2.1.1.4 Perceived barriers 
Perceived barriers refer to an individual's own evaluation of the obstacles in the 
way of him or her adopting a new behaviour. Of all the constructs, perceived 
barriers are the most significant in determining behaviour change (Rosenstock et 
a/., 2004:5-25). The major constructs of perception are modified by other 
variables such as culture, education level, past experiences, skill and motivation. 
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These are individual characteristics that influence personal characteristics 
(Turner et a!., 2004: 72). The study will identify barriers in complying to the 
recommended TB treatment. 
The health belief model is relevant for this study, because the underlying concept 
is that health behaviour (non-compliance to TB treatment) is determined by 
personal beliefs or perceptions about a disease and strategies to decrease its 
occurrence (Ali, 2002:33). 
Figure 2.1 The Health Belief Model 
Socio-demographic factors 
• Sex 
• Age 
• Educational level 
• Race 
• Ethnicity 
• Emnlovment status 
Perceived benefits of action 
• Knowledge about TB, 
treatment and importance of 
compliance to treatment 
Perceived barriers to action 
• Socio-cultural and health-
related issues affecting 
patients' compliance to TB 
treatment 
Behaviour to reduce 
threat based on 
expectations 
Source: Umeh & Rogan-Gibson (2001 :361-673) 
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Perceived susceptibility 
• Belief that you are suffering 
from TB 
• Belief that the TB diagnostic 
method used is accurate 
Perceived severity of ill health 
condition 
• Perceptions or knowledge of 
dangers of not complying to 
TB treatment 
I 
CHAPTER 3: RESEARCH DESIGN AND METHOD 
3.1 RESEARCH PARADIGM 
This was a quantitative study aimed at describing the variables and identifying 
the relationship among variables, these being non-compliance and social, 
cultural and health system related factors as advised by Hopkins (2000:27). 
Quantitative research was used to profile adult pulmonary TB patients by 
determining their behavioural intentions, attitudes and knowledge related to TB 
and to identify specific determinants which predicted non-compliance to 
treatment among these patients at a statistically significant level (Scott, 2002:12). 
The advantage of using this design was that it provided the researcher with a 
clearer picture of what to expect in her research (Hopkins, 2000:27). 
3.2 AREA OF STUDY/LOCATION 
The study was conducted in 12 primary health care facilities in Mogalakwena and 
Modimolle sub-districts, Waterberg District in the Limpopo province. 
3.3 TARGET POPULATION, SAMPLE AND SAMPLING METHOD 
3.3.1 Target population 
There were only 215 clinic based TB patients aged 18-49 years who were 
recruited to participate in this study, they resided in Waterberg District. Since the 
population was not large, a total population study was done and there was no 
need for sampling. 
3.3.2 The instrument 
A Questionnaire was used for data collection from participants in this study. The 
questionnaire was divided into the following sections; 
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Section A: Demographic information; 
Section B: Socioeconomic variables; 
Section C: Client related factors; 
Section D: Health system related factors; 
Section E: Socioeconomic barriers; and 
Section F: Disease and medicine related barriers 
3.3.3 Data-collection approach 
Data collection was done using the interviewer administered questionnaire to 
study participants as they were queuing for TB services. Each participant was 
moved away from the other TB patients whilst the questionnaire was being 
administered. Although the questionnaire was in English, questions were asked 
in the local language in order to increase understanding of questions by the 
participants. 
3.3 4 Data analysis 
In this study, a statistician analysed the data using the Statistical Package for 
Social Sciences (SPSS) version 11.0 computer program. The Chi-square test 
was used to compare different proportions and the association between 
variables. The 5% level of significance was used as the cut off for statistical 
significance. Descriptive statistics of frequency distributions and measures of 
dispersion were used to describe study variables. 
3.4 Ethical considerations related to data collection 
Ethical considerations related to data collection in this study included the 
principle of respect for human dignity, principle of anonymity and confidentiality, 
principle of beneficence and the principle of justice. 
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i) Principle of respect for human dignity 
The principle of respect for human dignity states that human beings have the 
right to be respected and the right to have their decisions respected (Polit & 
Beck, 2008: 88). Participants were given the opportunity to choose to participate 
in the study (Mouton, 2003:243). Privacy was enhanced by administering the 
questionnaire to one patient at a time away from other patients. 
ii) Principle of anonymity and confidentiality 
Study informants remained anonymous. The identities of all participants were 
kept secret. Codes were used instead of participants' names and surnames as 
advised by Mouton (2003:243). To ensure confidentiality, all collected information 
was stored privately in a lockable cabinet in line with Babbie and Mouton's 
(2002:521) advice. 
iii) Principle of beneficence 
The ethical principle of beneficence, holds that one should do good and, above 
all, do no harm (Burns & Grove 2005:190).This study ensured that participants 
were protected from psychological or emotional harm, by explaining the purpose 
of the study, exploring any fears and addressing them as advised by Babbie & 
Moutons (2002:521 ). There were no anticipated negative effects for the 
respondents, as the study was non-experimental. 
iv) Principle of justice 
This principle holds that each person should be treated fairly and should receive 
what he or she is due or owed (Burns & Grove 2005:189). All participants were 
treated fairly without discrimination and the researcher was guided by 
professional ethics as she is a registered nurse. The researcher also ensured 
that research ethics of upholding the participants' rights were observed. 
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3.5 LIMITATIONS OF THE STUDY 
The researcher identified the following limitations in the study: 
• The findings could not be generalised to other parts of the country, as the 
sample was not large enough and was obtained using convenience 
sampling. 
• No opinions were obtained from the health workers and treatment 
supervisors. 
• The scope of the study was limited to adults (18-49 years), hence views 
for TB patients below 18 years were not captured. 
• Data obtained through the cross-sectional study design may not be rich 
enough to be extrapolated on a longitudinal study. 
• Resources to support research were inadequate since the researcher had 
to personally fund the study. 
• There was limited time to conduct research. 
• The researcher is not very experienced in conducting research. 
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CHAPTER 4: THE RESULTS 
SECTION 1: DEMOGRAPHY 
The demographic factors included age, gender, marital status, race, level of 
education and rel igion. Analysis was done for 212 respondents out of the 215 
who were interviewed. The demographic factors are presented below. 
4.1.1 Age in years (N=212) 
The questionnaire categorised respondents into age groups. The age distribution 
is displayed in Figure 4.1 (below) . 
Age distribution of patients {N=212) 
60 
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Age In years 
Fig 1: Age distribution of all the respondents 
This graph shows that 14% of the study respondents were aged between 18-25 
years, 22% were aged 26-33 years and 28% were between 34-41 years old. 
Respondents aged between 42-49 years were 25% and 11% were aged between 
50-57 years. Only 2% of the respondents were aged between 58-65 years, whilst 
4% were between 66-73 years old. Respondents aged >73 years were only 
0.5%. 
37 
4.1.2 Gender (N=212) 
Respondents were asked to state their gender. Of 212 respondents, 98 (46%) 
were males and 114 (54%) were females. This indicates that a higher proportion 
of the respondents were females. Cross tabulation of gender and compliance to 
TB treatment is shown in section 4.8.3. 
Table 1: Respondents' gender (N=212) 
Male 
Female 
Total 
4.1.3 Marital status (N=212) 
114 
212 
54% 
100% 
Each respondent was asked their marital status (single, married, living with 
partner, divorced, separated or widowed). Only 42 (20%) of the study participants 
reported to be married. A significant proportion, 91 (43%) of the respondents 
were single. Respondents living with a partner were 34 (16%) whilst 45 (21 %) 
were either divorced, separated or widowed. Marital status and compliance to TB 
treatment is cross tabulated in section 4.8.4. 
Table 2: Respondents' marital status (N=212) 
Single 
Married 42 20% 
Living with partner 34 16% 
Divorced/Separated/Widowed 45 21 % 
Total 212 100% 
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4.1.4 Race (N=212) 
Respondents were asked their race. The highest proportion of the study 
participants were black, 196 (92%) and most of them 112 (57%) were in the non-
compliant group. Only 1 (0.5%) of the respondents was white whilst 15 (7%) 
were coloured. A higher proportion (12) 80% of the coloured respondents were in 
the compliant group. None of the study participants were Indian. Race and 
compliance to TB treatment is cross tabulated in section 4.8.5. 
4.1.5 Highest level of education attained (N=212) 
The respondents were asked the highest level of education they had attained. 
Fig. 2 (below) shows the majority, 58 (27%) of the respondents only attained 
secondary education level. Participants who had attained matric education level 
were 46 (22%). Thirty six (17%) of the respondents had a primary level education 
and 24 (11 %) had no education at all. Cross tabulation of the level of education 
and compliance to TB treatment is presented in section 4.8.6. 
Highest level of education attained (N=212) 
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Fig 2: Highest level of education attained 
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Matric Tertiary 
4.1.6 Religion (N=212) 
A total of 127 (60%) respondents reported they were of other religions. Eighty 
two (39%) were Christians. Christians were equally distributed in both the 
compliant and non-compliant groups. The religion practiced did not account for 
any significant difference between the two groups (P=0.243) . Only 3 (1 %) of the 
respondents were Muslims. 
SECTION 2: SOCIOECONOMIC VARIABLES 
Socioeconomic variables included employment status, income per month and 
availability of food whilst taking TB treatment. 
4.2.1 Employment status of respondents (N=212) 
Respondents were asked to indicate their employment status. One hundred and 
fifteen (54%) indicated that they were unemployed and 70 (33%) were employed. 
Twenty seven (13%) of the respondents were self-employed (see figure 1 ). 
Employment status and compliance to TB treatment is cross tabulated in section 
4.8.7. 
nt status (N=212) 
Fig 3: Respondents' employment status 
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• Employed 
• Unemployed 
• Self employed 
4.2.2 Respondents' income per month (N=212) 
The highest number of respondents 121 (57%) reported having no income at all 
and a higher proportion of those respondents 70 (58%) were in the non-
compliant group. Respondents with an income of R1000-R2000 per month were 
33 (16%) whilst study participants with an income above R2000 per month were 
55 (26%). Of these participants, a higher proportion 41 (75%) were in the 
compliant group. Only 3 (1 %) of the respondents reported having an income of 
less than R1 000 per month. 
Fig 4: Respondents' income per month 
4.2.3 Availability of food whilst taking TB treatment 
• None 
• <1000 
• 1000-2000 
• >2000 
Eighty percent of the respondents reported that they always have food whilst 
taking TB treatment. A higher proportion 156 (92%) of these respondents were in 
the compliant group. Only 43 (20%) of the study participants reported that they 
do not always have food whilst taking TB treatment. Of these participants a 
higher proportion 31 (72%) were in the non-compliant group while only 12 (28%) 
were in the compliant group. None of the participants reported that they never 
have food. Availability of food and compliance to TB treatment is cross tabulated 
in section 4.8.8. 
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Table 3: Availability of food whilst taking TB treatment (N=212) 
Always available 
Not always available 
Never available 
Total 
-~~.~.---
SECTION 3: CLIENT-RELATED FACTORS 
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0 
212 
0% 
100% 
Client-related factors which were assessed included the questions: "do you 
believe that you are suffering from TB?", "do you think that the TB diagnostic 
method used is accurate?" and statements like "TB can result in death if not 
treated" and "TB can be cured if TB treatment is taken daily for the correct 
treatment duration". Further questions such as "why is it important to take TB 
treatment for the prescribed duration?" and "are you currently receiving the 
disability grant and are you receiving any food packages?". 
4.3.1 Do you believe that you are suffering from TB? 
The respondents were asked whether they believed they were suffering from TB. 
One hundred and eighty five (87%) of the respondents reported that they 
believed that they were suffering from TB. A higher proportion of these 
respondents (89%) were in the compliant group. Study participants who reported 
that they do not believe that they are suffering from TB numbered 27 (13%). Of 
these participants only 11% were in the compliant group. A cross tabulation of 
whether respondents believed they were suffering from TB and compliance to TB 
treatment is shown in section 4.8.9. 
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Table 4: Respondents' responses on whether they believe they are 
suffering from TB (N=212) 
Yes 
No 
Total 
27 
212 
87% 
13% 
100% 
4.3.2 Do you think that the TB diagnostic method used is accurate? (N=212) 
Respondents were asked if they think that the TB diagnostic method used is 
accurate and 163 (77%) reported that they believed that it is. A higher proportion 
of those participants (81 %) were in the compliant group. Only 49 (23%) study 
participants reported that they did not believe that the TB diagnostic method used 
was accurate and only 19% of those participants were in the compliant group. A 
cross tabulation of whether participants think the TB diagnostic method used was 
accurate and compliance to TB treatment is shown in section 4.8.1 0. 
4.3.3 TB can result in death if not treated (N=212) 
When asked whether they believed that TB can result in death if not treated, 204 
(96%) reported that TB it can and 98% of those respondents were in the 
compliant group. Only 8 (4%) of the respondents said no, TB cannot result in 
death if not treated and only 2% of these were in the compliant group. A cross 
tabulation of whether respondents bel ieved that TB can result in death if not 
treated and compliance to TB treatment is shown in section 4.8.11 . 
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4.3.4 TB can be cured if TB treatment is taken daily for the correct 
treatment duration (6-8 months) N=212 
There were 205 (97%) respondents who indicated that they believed that TB can 
be cured if treatment is taken daily for the correct treatment duration. Of these 
205 patients, 97% were in the compliant group. Only 7 (3%) of the participants 
indicated that TB can still be cured even if treatment is not taken daily for the 
correct treatment duration. A cross tabulation of whether respondents believed 
that TB can be cured if treatment is taken daily for the correct duration and 
compliance to treatment is shown in section 4.8.12. 
4.3.5 Why is it important to take TB treatment for the prescribed duration 
(6-8 months)? N=212 
When respondents were asked why it is important to take TB treatment for the 
prescribed duration their responses were as follows; 153 (72%) indicated to 
prevent drug resistant TB, 208 (98%) stated that to be cured, whilst 165 (78%) of 
the respondents indicated to prevent the spread of TB. Participants who 
indicated that to prevent death were 186 (88%). Of the respondents who 
indicated to prevent drug resistant TB, a higher proportion (80%) were in the 
compliant group and 98% of the respondents who said they wanted to be cured 
were in the compliant group. 
A high proportion (81 %) of participants who indicated to prevent the spread of TB 
were in the compliant group and of the respondents who indicated to prevent 
death, 88% were in the compliant group. Participants' reasons for taking TB 
treatment for the prescribed duration and compliance to TB treatment are cross 
tabulated in section 4.8.13. 
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Table 5: Respondents' reasons for taking TB treatment for the prescribed 
duration (N=212) 
To prevent drug resistant TB 
To be cured 
To prevent the spread of TB 
To prevent death 
208 
165 
186 
4.3.6 Are you currently receiving a disability grant (N=212)? 
78% 
88% 
Respondents were asked whether they are receiving a disability grant. Seventy 
seven (36%) of the respondents indicated that they are receiving a disability 
grant whilst 135 (64%) reported that they are not receiving any grant. There was 
no significant difference between the compliant and non-compliant groups with 
respect to the disability grant question (P=0.229). 
4.3.7 Are you receiving any food packages (N=212)? 
When asked whether they were receiving any food packages, 205 (97%) 
indicated that they are not receiving any food packages whilst only 7 (3%) 
reported that they are. There was no significant difference in compliance 
between respondents who were receiving food packages and those who were 
not (P=0.0220). 
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Respondents' responses to receiving food packages 
(N=212) 
• Food package 
• No food package 
Fig 5: Respondents' responses to receiving food packages 
SECTION 4: HEALTH SYSTEM RELATED FACTORS 
4.4.1 How are the healthcare workers' attitudes in the clinic/facility of 
treatment (N=212)? 
Respondents were asked about the health-care workers' attitudes in the facility of 
treatment. One hundred and fifty nine (75%) of the respondents reported that staff 
were friendly and 160 (75%) indicated that staff are also caring. Of the participants 
who said staff were caring, 78% were in the compliant group. Participants who 
indicated that staff were rude were 51 (24%) whilst 53 (25%) reported that staff are 
uncaring. Of the participants who said staff were rude, only 21 % were in the 
compliant group. A cross tabulation of participants responses on health care worker 
attitudes and compliance to TB treatment is shown in section 4.8.14. 
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Fig 6: Respondents' views on healthcare workers' attitudes 
4.4.2 How much time do you spend in the clinic/facility for monthly refill of TB 
treatment (N=212) 
When asked about the time they spend in the facil ity for monthly refill of TB 
treatment, 81 respondents (38%) indicated that they spend less than 1 hour whilst 
76 (36%) reported that they spend 2-3 hours. A higher proportion (61 %) of the 
respondents who spent less than 1 hour in the facility were in the compliant group. 
Of the respondents who spent 2-3 hours in the facility, only 53% were in the 
compliant group. There were 55 (26%) study participants who reported spending 
more than 3 hours in the facility. Of those participants, only 51 % were in the 
compl iant group. Time spent in the facility and compliance to TB treatment is cross 
tabulated in section 4.8.14. 
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Respondents• responses on time spent in the 
clinic/facility (N=212) 
II <1 hour 
11 2-3 hours 
5i >3 hours 
Fig 7: Respondents' responses to time spent in the facility/clinic 
4.4.3 How far do you travel to collect your TB medicines (Km) N=212? 
Respondents were asked how far they travel to collect TB medicines. 
Respondents who indicated that they travel less than 5 km were 59 (28%) whilst 
73 (34%) reported travelling between 5 and 1 Okm. Of the participants who travel 
less than 5km, 31 (35%) were in the compliant group. Fifty four (26%) of the 
respondents indicated travelling between 11 and 15km whilst 26 (12%) reported 
travelling more than 15km to collect their TB medicines. Only 8% of the 
participants who travelled more than 15km were in the compliant group. The 
distance travelled by respondents to collect their TB medicines and compliance 
to TB treatment are cross tabulated in section 4.8.15. 
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Distance travelled by respondents for TB 
medicines (N=212) 
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Fig 8: Distance travelled by respondents to collect TB medicines 
4.4.4 Do the operating times for the clinic/facility make it easy for you to 
receive treatment any time you need it (N=212)? 
When asked whether the operating times of the clinic/facility make it easy for 
respondents to receive treatment anytime they need it, 167 (79%) said yes and 
only 45 (21 %) said no. A cross tabulation of whether the facility operating times 
make it easy for respondents to receive treatment anytime they need it and 
compliance to treatment is shown in section 4.8.16. 
Table 6: Do clinic operating times make it easy for respondents to receive 
TB treatment (N=212) 
No 
Total 
49 
45 
212 
21 % 
100% 
4.4.5 How much does it cost for you to reach the clinic/facility from home 
(Rands) N=212? 
Respondents were asked how much it costs them to reach the clinic. A high 
proportion 162 (76%) reported spending R1 O-R50 and of those participants, 74% 
were in the compl iant group. Participants who indicated that they spend less than 
R1 0 were 31 (15%) whilst 19 (9%) reported spending more than R50. The cost 
for respondents to reach the clinic/facility from home and compliance to 
treatment are cross tabulated in section 4.8.17. 
Amount spent (R) by repondents 1:o reach the clinic 
(N=212} 
Fig 9: Amount spent (R) by respondents to reach the clinic 
SECTION 5: SOCIO-CULTURAL BARRIERS 
4.5.1 TB can be cured by using traditional medicines (N=212) 
• < R1 0 
• R 10-RS O 
lliii > RSO 
Respondents were asked whether they bel ieved that TB can be cured using 
traditional medicines. Sixty eight (32%) believed that TB can be cured using 
traditional medicines and 144 (68%) did not believe that it can be cured using 
traditional medicines. 
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A cross tabulation of whether participants believed that TB can be cured by using 
traditional medicines and compliance to treatment is shown in section 4.8.18. 
Respondents• beliefs on traditional medicine 
(N=212) 
a TB can be cu red by using traditional medicines 
a TB cannot be cured by using traditional medicines 
Fig 10: Respondents' beliefs on traditional medicine 
4.6 DETERMINING COMPLIANCE PATTERNS AMONG PULMONARY TB 
PATIENTS IN WATERBERG DISTRICT 
To determine compliance patterns among pulmonary TB patients in Waterberg 
District, compl iance patterns were assessed in relation to demographic, health-
related as well as disease and medicine-related factors. To measure compliance, 
respondents were asked whether they had ever missed a dose of their TB 
treatment. 
4.6.1 Have you ever missed your dose(s) of TB drugs before (N=212)? 
When respondents were asked whether they had ever missed a dose of TB 
drugs before, 62 (29%) reported to have missed a dose whilst 150 (71 %) 
indicated that they have never missed a dose. 
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Respondents• responses on whether they 
missed a dose of TB drugs before (N=212) 
8 Yes & No 
Fig 11: Have you ever missed your dose(s) of TB drugs before? 
4.6.2 Compliance patterns among pulmonary TB patients by age group 
(N=212) 
Respondents aged 26-49 years were the most non-compliant. Twenty four 
percent of these participants had missed a dose of their TB drugs before. The 
most compliant respondents were aged 58-65 years. Of these participants only 
5% had ever missed their TB drugs as shown in table 7 below. 
Table?: Compliance patterns by respondents' age group (N=212) 
Missed 
TB 
dose 
before 13% 24% 24% 24% 10% 5% 100% 
Never 
missed 
TB 
dose 15% 21 % 19% 26% 11 % 1% 5% 1% 100% 
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4.6.3 Compliance patterns among pulmonary TB patients by gender 
(N=212) 
Of the 150 respondents who reported to have never missed a dose of their TB 
drugs, 84 (56%) were females and only 66 (44%) were males. This is shown in 
table 8 below. Gender was not statistically associated with non-compliance to TB 
treatment (P=0.636). 
Table 8: Compliance patterns by respondents' gender (N=212) 
before 
Never missed 
TB dose 
56% 
44% 
44% 100% 
56% 100% 
4.6.4 Compliance patterns among pulmonary TB patients by marital status 
(N=212) 
Forty seven (47%) of the single respondents had never missed a dose of their TB 
drugs. Of the married participants, 18% had never missed a dose of their TB 
treatment. Participants who reported to have never missed a dose of their TB 
treatment and were living with partner were 13% and those who are divorced, 
separated or widowed were 22%. This is shown in table 8 below. Marital status 
was however not statistically associated with non-compliance to TB treatment 
(P=0.506). 
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Table 9: Compliance patterns by respondents' marital status (N=212) 
dose 
before 
Never 
missed TB 
dose 
34% 
47% 18% 
19% 100% 
13% 22% 100% 
4.6.5 Compliance patterns among pulmonary TB patients by race (N=212) 
Compliance to TB treatment was higher in black respondents since 73% of the 
black participants reported to have never missed a dose of their TB treatment. Of 
the coloured respondents, only 3% reported to have never missed a dose. There 
was only 1 white participant (n=1 ) who had never missed a dose of TB treatment, 
but because of the number being only 1, compliance was compared between the 
coloured and black participants. This is shown in table 10 below. Race was not 
statistically associated with non-compliance to TB treatment (P=0.112). 
Table 10: Compliance patterns by respondents' race (N=212) 
before 
Never missed TB 
dose before 
Total 
27% 
73% 
100% 
100% 
100% 
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97% 
3% 
100% 
4.6.6 Compliance patterns among pulmonary TB patients by educational 
level (N=212) 
Of the respondents who have matric, 17% had never missed a dose of their TB 
drugs before. Of the participants with a tertiary educational level, 19% had never 
missed a dose. Thirty one (31 %) participants who had secondary education level 
had never missed a dose of their TB drugs and 14% of participants with no 
education at all had never missed a dose. These statistics are presented in table 
11 below. However, education level was not statistically associated with non-
compliance to TB treatment (P=0.168). 
Table 11: Compliance patterns by respondents' educational level (N=212) 
before 
Never 
missed 
TB dose 
5% 
14% 
11% 
19% 31 % 17% 19% 100% 
4.6.7 Compliance patterns among pulmonary TB patients by employment 
status (N=212) 
Twelve percent (12%) of the participants who are self-employed had never 
missed a dose of their TB drugs before. Of the participants who were 
unemployed, 56% had never missed a dose, whilst 32% of the employed 
participants reported to have never missed a dose. This is shown in Table 10. 
Employment status was however not statistically associated with non-compliance 
to TB treatment (P=0.670). 
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Table 12: Compliance patterns by respondents' employment status (N=212) 
dose before 
Never 
missed TB 
dose 32% 
50% 
56% 
15% 
12% 100% 
4.6.8 Compliance patterns among pulmonary TB patients by availability of 
food (N=212) 
Participants who reported to have never missed a dose of their TB treatment 
were higher (83%) amongst those who indicated that food was always available 
compared to respondents who reported that food was not always available 
(18%). This is shown in table 13 below. Non-availability of food was associated 
with non-compliance to TB treatment (P=0.01 ). 
Table 13: Compliance patterns by availability of food (N=212) 
before 
Never missed TB 
dose 
Total 
17% 
83% 
100% 
56 
82% 
18% 
100% 
4.6.9 Compliance patterns among pulmonary TB patients by whether they 
believe they are suffering from TB (N=212) 
Of the respondents who believed that they were suffering from TB, 89% reported 
to have never missed a dose of their TB drugs before, whilst only 11% of the 
participants who did not believe that they were suffering from TB had never 
missed a dose. This is shown in table 14 below. Not bel ieving that you are 
suffering from TB was not statistically associated with non-compliance to TB 
treatment (P=0.503). 
Table 14: Compliance patterns by whether respondents believed that they 
are suffering from TB (N=212) 
before 
Never missed TB 
dose 
Total 
11 % 
89% 
100% 
89% 
11% 
100% 
4.6.10 Compliance patterns among pulmonary TB patients by whether 
respondents believe that the diagnostic method was accurate (N=212) 
Of the respondents who believed that the diagnostic method used was accurate, 
81 % had never missed a dose of their TB drugs before, whilst only 19% of the 
participants who did not believe that the diagnostic method used was accurate 
had never missed a dose. This is shown in table 15 below. Statistically there was 
no significant difference in compliance between participants who believed and 
those who did not (P=0.684). 
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Table 15: Compliance patterns by whether respondents believed that the 
diagnostic method used was accurate (N=212) 
Missed TB dose before 
Never missed TB dose 
Total 
81% 
100% 
19% 
100% 
4.6.11 Compliance patterns among pulmonary TB patients by whether 
respondents believed that TB can result to death if not treated (N=212) 
Of the respondents who believed that TB can result in death if not treated, 98% 
had never missed a dose of their TB drugs before, whi lst only 2% of the 
participants who did not bel ieve that TB can result to death if not treated had 
never missed a dose. This is shown in table 16 below. Not believing that TB can 
result in death if not treated was statistically associated with non-compliance to 
TB treatment (P=0.04). 
Table 16: Compliance patterns by whether respondents believed that TB 
can result in death if not treated (N=212) 
Missed TB dose before 
Never missed TB dose 
Total 
58 
98% 
100% 
2% 
100% 
4.6.12 Compliance patterns among pulmonary TB patients by whether 
respondents believed that TB can be cured if treatment is taken daily for 
the correct duration (N=212) 
Of the participants who believed that TB can be cured if treatment is taken daily 
for the correct duration, 97% had never missed a dose of their TB drugs before, 
whilst only 36% of the respondents who did not believe had never missed a 
dose. This is shown in table 17 below. Not believing that TB can be cured if 
treatment is taken daily for the correct duration was not statistically associated 
with non-compliance to TB treatment (P=0.451 ). 
Table 17: Compliance patterns by whether respondents believed that TB 
can be cured if treatment is taken daily for the correct duration (N=212) 
Missed TB dose before 
Never missed TB dose 
Total 
97% 
100% 
36% 
100% 
4.6.13 Compliance patterns among pulmonary TB patients by participants' 
responses on why it is important to take TB treatment for the prescribed 
duration (N=212) 
Of the respondents who indicated that it is important to take TB treatment for the 
prescribed duration in order to prevent drug resistance, 80% had never missed a 
dose of their TB treatment. Those participants who indicated that it is important to 
take TB treatment for the prescribed duration to be cured, 98% had never missed 
a dose of their TB treatment, whilst 81 % of those who said to prevent the spread 
of TB, had never missed a dose of their TB treatment. 
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Of the participants who said to prevent death, 88% had never missed a dose. 
This is shown in table 18 below. This factor was not statistically associated with 
compliance or non-compliance to TB treatment (P=0.289). 
Table 18: Compliance patterns by participants' responses on why it is 
important to take TB treatment for the prescribed duration (N=212) 
Missed TB dose before 2% 19% 12% 100% 
Never missed TB dose 80% 98% 81 % 88% 100% 
4.6.14 Compliance patterns among pulmonary TB patients by participants' 
responses on healthcare workers' attitudes at the clinic/facility of treatment 
(N=212) 
Of the respondents who reported healthcare workers in the clinic or facility of 
treatment to be friendly, 77% had never missed a dose of their TB drugs before, 
78% of those who reported healthcare workers to be caring had never missed a 
dose. Of the participants who indicated that healthcare workers were rude, 21 % 
had never missed a dose whilst 22% of those who reported that healthcare 
workers were uncaring had never missed a dose. This is shown in table 19 
below. Bad healthcare workers ' attitudes were statistically associated with non-
compliance to TB treatment (P=0.021 ). 
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Table 19: Compliance patterns by participants' responses to healthcare 
workers' attitudes at the clinic/facility of treatment (N=212) 
Missed TB dose before 
Never missed TB dose 77% 21 % 22% 
Total 100% 100% 100% 100% 
4.6.15 Compliance patterns among pulmonary TB patients by participants' 
responses on how much time was spent in the clinic/facility for monthly 
refill of TB treatment (N=212) 
Of the respondents who spent <1 hour in the clinic or facility for monthly refill of 
TB treatment, 61 % had never missed a dose of their TB drugs before, whilst 53% 
of those who spent between 2-3 hours had never missed a dose. Of the 
participants who spent >3 hours, only 51 % had never missed a dose of their TB 
drugs before as shown in table 20 below. This factor was not statistically 
associated with compliance or non-compliance to TB treatment (P=0.265). 
Table 20: Compliance patterns by participants' responses on how much 
time is spent in the clinic/facility for monthly refill of TB treatment (N=212) 
Missed TB dose before 
Never missed TB dose 
Total 
39% 
61 % 
100% 
61 
47% 49% 
53% 51 % 
100% 100% 
4.6.16 Compliance patterns among pulmonary TB patients by participants' 
responses on the distance travelled to collect TB medicines (N=212) 
Of the respondents who travelled <5km to collect their TB medicines, 35% had 
never missed a dose of their TB drugs before, whilst 33% of the participants who 
travelled 5-1 Okm had never missed a dose. Of the respondents who travelled 11-
15km, 23% had never missed a dose whilst of those who travelled > 15km, 84% 
had never missed a dose. This is shown in table 21 below. Longer distance 
travelled to clinic to collect TB medicines was statistically associated with non-
compliance to TB treatment (P=0.015). 
Table 21: Compliance patterns by participants' responses on the distance 
travelled to collect TB medicines (N=212) 
Missed TB dose before 65% 67% 92% 
Never missed TB dose 35% 33% 23% 8% 
4.6.17 Compliance patterns among pulmonary TB patients by participants' 
responses on whether the clinic operating times make it easy to receive TB 
treatment anytime (N=212) 
Of the participants who indicated that the operating times of the clinic make it 
easy for them to receive TB treatment anytime they need it, 88% never missed a 
dose of their TB drugs before. Of the respondents who reported that the clinic 
operating times do not make it easy for them to receive TB treatment anytime 
they need it, only 12% had never missed a dose. Clinic operating times were 
however not statistically associated with non-compliance to TB treatment 
(P=0.215). 
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Table 22: Compliance patterns by participants' responses on whether the 
clinic operating times make it easy to receive TB treatment anytime (N=212) 
Missed TB dose before 12% 89% 
Never missed TB dose 88% 11 % 
Total 100% 100% 
4.6.18 Compliance patterns among pulmonary TB patients by participants' 
responses on the money spent (cost) to travel to the clinic for monthly refill 
of TB treatment (N=212) 
Of the respondents who spend <R1 0 to travel to the clinic for monthly refill of TB 
treatment, 19% had never missed a dose of their TB drugs before, whilst of those 
who spent R10-R50, only 74% had never missed a dose. Of the respondents 
who reported spending >R50, 7% had never missed a dose, as shown in table 23 
below. This factor was not statistically associated with compliance or non-
compliance to TB treatment (P=0.408). 
Table 23: Compliance patterns by participants' responses on the money 
spent (cost) of travelling to the clinic for monthly refill of TB treatment 
(N=212) 
Missed TB dose before 81 % 26% 93% 
Never missed TB dose 19% 74% 7% 
Total 100% 100% 100% 
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4.6.19 Compliance patterns among pulmonary TB patients by participants' 
responses on whether TB can be cured by using traditional medicines 
(N=212) 
Of the respondents who believed that TB can be cured using traditional 
medicines, 23% had never missed a dose of their TB treatment before, whilst of 
those who did not believe that TB can be cured using traditional medicines, 77% 
had never missed a dose, as shown in table 24 below. Believing that TB can be 
cured using traditional medicines was statistically associated with non-
compliance to TB treatment (P=0.025). 
Table 24: Compliance patterns by participants' responses on whether TB 
can be cured by using traditional medicines (N=212) 
Missed TB dose before 77% 23% 
Never missed TB dose 23% 77% 
Total 100% 100% 
4.7 DETERMINING FACTORS CONTRIBUTING TO NON-COMPLIANCE TO 
TB TREATMENT (N=212) 
To determine factors contributing to non-compliance to TB treatment, 
respondents were asked the reasons for missing doses of their TB treatment. 
Health, disease and medicine-related factors contributing to non-compliance to 
TB treatment were also assessed. 
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4.7.1 What was the reason (s) for missing your TB medication (N=212) 
A total of 62 pulmonary TB patients indicated that they had missed their dose(s) 
of TB treatment. Of those who indicated they had, 19 (31 %) reported that they 
felt better and as a result felt no need to continue taking their treatment. Fourteen 
(22%) missed their doses as a result of side effects whilst only 2 (3%) patients 
reported that they had been taking traditional medicines at the time and decided 
not to continue taking TB treatment A total of 27 (44%) respondents highlighted 
other reasons and these included; lack of money to go to the clinic for TB 
treatment, long distance to the clinic and being out of the country for some time 
during their TB treatment. 
4.7.2 Disease and medicine-related factors contributing to non-compliance 
to TB treatment (N=212) 
Respondents were asked what are the reasons for not completing TB treatment 
and a higher proportion 174 (82%) indicated side effects of TB drugs as the main 
reason for not completing treatment. One hundred and twenty four (58%) 
indicated that TB treatment takes very long whilst 59 (28%) indicated too many 
pills to take as another reason for not completing treatment. Respondents who 
indicated the reason as TB can still be cured even if treatment is not completed 
were only 23 (11 %). 
Table 25: Respondents' reasons for not completing TB treatment (N=212) 
Treatment takes 
very long to 
TB can still be 
cured even if 
treatment is not 
4.7.3 Non-compliance patterns by respondents' reasons for not completing 
TB treatment 
4.7.3.1 Non-compliance patterns by participants' response that TB treatment 
takes very long to complete (N=124) 
A total of 124 respondents indicated the reason for not completing TB treatment 
is that it takes very long. Of the 124 respondents, 102 (82%) reported that they 
had missed a dose of their TB treatment before as shown in table 26 below. The 
feeling that TB treatment takes very long was associated with non-compliance to 
treatment (P=O.OOO). 
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Table 26: Have you ever missed your dose(s) of TB drugs before* Reasons 
for not completing TB treatment; treatment takes very long to complete 
(N=124) 
Reasons for not completing TB 
treatment· treatment takes very long 
to complete 
yes no Total 
Have you ever missed your yes Count 51 11 62 
dose(s) of TB drugs before Expected Count 36.3 25.7 62.0 
% within Have you ever 82.3% 17.7% 100.0% 
missed your dose(s) of TB 
drugs before 
%of Total 24.1% 5.2% 29.2% 
no Count 73 77 150 
Expected Count 87.7 62.3 150.0 
%within Have you ever 48.7% 51.3% 100.0% 
missed your dose(s) of TB 
drugs before 
%of Total 34.4% 36.3% 70.8% 
Total Count 124 88 212 
Expected Count 124.0 88.0 212.0 
%within Have you ever 58.5% 41.5% 100.0% 
missed your dose(s) of TB 
drugs before 
%of Total 58.5% 41.5% 100.0% 
P=O.OOO 
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4. 7.3.2 Non-compliance patterns by participants' reason for not completing TB 
treatment; side effects of anti-TB drugs (N=174) 
Of the 17 4 participants who reported side effects of anti-TB drugs to be a reason 
for not completing treatment, 87% had missed a dose of their TB drugs before as 
shown in table 27 below. Side effects of anti-TB drugs were not statistically 
associated with non-compliance to TB treatment (P=0.220). 
Table 27: Have you ever missed your dose(s) of TB drugs before* Reasons 
for not completing TB treatment- side effects of anti-TB drugs (N=174) 
Reasons for not completing TB 
treatment- side effects of anti-
TB drugs 
yes no Total 
Have you ever missed yes Count 54 8 62 
your dose(s) of TB drugs Expected Count 50.9 11.1 62.0 
before 
% within Have you ever 87.1% 12.9% 100.0% 
missed your dose(s) of TB 
drugs before 
%of Total 25.5% 3.8% 29.2% 
no Count 120 30 150 
Expected Count 123.1 26.9 150.0 
~Yo within Have you ever 80.0% 20.0% 100.0% 
missed your dose(s) of TB 
drugs before 
%of Total 56.6% 14.2% 70.8% 
Total Count 174 38 212 
Expected Count 174.0 38.0 212.0 
% within Have you ever 82.1% 17.9% 100.0% 
missed your dose(s) of TB 
drugs before 
%of Total 82.1% 17.9% 100.0% 
P=0.220 
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4.7.3.3 Non-compliance patterns by respondents who think that too many pills to 
take are a reason for not completing TB treatment (N=59) 
A total of 59 respondents indicated that the issue regarding too many pills was 
responsible for not completing TB treatment. Of those participants, 39% reported 
to have missed a dose of their TB treatment before. This is shown in the table 28 
below. Too many pills to take as a reason was statistically associated with non-
compliance to TB treatment (P=0.023). 
Table 28: Have you ever missed your dose(s) of TB drugs before* reasons 
for not completing TB treatment- too many pills to take daily (N=59) 
Reasons for not completing TB 
treatment- too many pills to take daily 
yes no Total 
Have you ever missed your yes Count 24 38 62 
dose{s) of TB drugs before 
Expected Count 17.3 44.7 62.0 
"!o within Have you ever missed 38.7% 61.3% 100.0% 
your dose(s) of TB drugs before 
%of Total 11.3% 17.9% 29.2% 
no Count 35 115 150 
Expected Count 41.7 108.3 150.0 
% within Have you ever missed 23.3% 76.7% 100.0% 
your dose(s) of TB drugs before 
%of Total 16.5% 54.2% 70.8% 
Total Count 59 153 212 
Expected Count 59.0 153.0 212.0 
% within Have you ever missed 27.8% 72.2% 100.0"/o 
your dose(s) of TB drugs before 
%of Total 27.8% 72.2% 100.0% 
P=0.023 
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4.7.3.4 Non-compliance patterns by respondents who think that TB can be cured 
even if treatment is not completed as a reason for not completing TB treatment 
(N=23) 
Of the 23 respondents who indicated that TB can still be cured even if treatment 
is not completed, 16% reported that they have missed a dose of their TB 
treatment before, as shown in Table 29 below. Believing that TB can still be 
cured even if treatment is not completed was not statistically associated with 
non-compliance to TB treatment (P=0.112). 
Table 29: Have you ever missed your dose(s) of TB drugs before* reasons 
for not completing TB treatment; TB can still be cured even if treatment is 
not completed (N=23) 
Reasons for not completing TB treatment-
TB can still be cured even if treatment is 
not completed 
yes no Total 
Have you ever missed your yes Count 10 52 62 
dose(s) of TB drugs before Expected Count 6.7 55.3 62.0 
% within Have you ever missed 16.1% 83.9% 100.0'% 
your dose(s) of TB drugs before 
%of Total 4.7% 24.5% 29.2% 
no Count 13 137 150 
Expected Count 16.3 133.7 150.0 
% within Have you ever missed 8.7% 91.3% 100.0% 
your dose(s) of TB drugs before 
%of Total 6.1% 64.6% 70.8% 
Total Count 23 189 212 
Expected Count 23.0 189.0 212.0 
% within Have you ever missed 10.8% 89.2% 100.0% 
your dose(s) of TB drugs before 
%of Total 10.8"/o 89.2% 100.0% 
P-0.112 
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Table 30: A summary of factors contributing to non-compliance to TB 
treatment amongst pulmonary TB patients 
Client-related factors 1. Non-availability of food whilst taking TB 
treatment 
2. Not believing that TB can result in death if 
not treated 
Socio-cultural factors 1. Belief in traditional medicines for curing TB 
Health service related factors 1. Bad healthcare worker attitudes 
2. Long distance to the clinic/facility of 
treatment 
Disease and medicine- 1. TB treatment duration- treatment takes too 
related factors long 
2. Pill burden- too many pills to take daily 
4.8 IN YOUR OPINION, WHAT COULD MAKE PATIENTS COMPLETE THEIR 
TB TREATMENT (N=212) 
A total of 116 participants responded to the question on what could make 
patients complete their TB treatment. A higher proportion 44 (38%) indicated that 
support from family members could make them complete their treatment. 
Eighteen (16%) of the respondents indicated that on-going education on dangers 
of not completing TB treatment should be given to TB patients. Only 4 (3%) 
participants stated that TB patients should not be discriminated against. This is 
shown in table 31 below. 
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Table 31: Respondents' opinions on strategies to enhance compliance to 
TB treatment (N=116) 
What could make patients complete their TB treatment Frequency Percent 
Support from family members 23 20% 
Drug holiday (on weekends) 8 7% 
On-going education on dangers of non-compliance to TB 
treatment 18 16% 
Clinics should open on weekends for TB drug refills 17 15% 
Avoid discrimination 4 3% 
Healthcare workers attitudes towards TB patients should 
chanqe 21 18% 
Effective management of side effects 12 10% 
Provision of food parcels for TB patients 13 11% 
Total 116 100% 
4.9 CONCLUSION 
This chapter focused on presenting the research findings as data analysis and 
interpretation. The study revealed that the majority of the respondents were non-
compliant to TB treatment because of non-availability of food whilst taking TB 
treatment, not believing that TB can result in death if not treated, belief in 
traditional medicines for curing TB, bad healthcare worker attitudes, long 
distances to the clinic/facility of treatment and lengthy TB treatment duration. 
The next chapter will discuss these findings and conclusions and make 
recommendations based on them. 
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CHAPTER 5: DISCUSSION, CONCLUSION AND RECOMMENDATIONS 
5.1 INTRODUCTION 
This chapter presents a discussion, the conclusion and recommendations made 
by the researcher. The discussion will focus on the research objectives of the 
study and compare the research findings with existing literature. 
5.2 AGES OF RESPONDENTS 
Although majority of the respondents were in the 34-41 age category, 
participants in the 42-49 years category were more compliant (26%) to TB 
treatment compared to the 34-41 age category (19%). There was no statistical 
significance indicating a relationship between age and compliance to TB 
treatment (P=0.471 ). These findings are consistent with a study conducted by 
Modise (2011 :51) in the Free State in which age was also not associated with 
non-compliance to TB treatment. 
5.3 RESPONDENTS' GENDER 
Compliance to TB treatment was higher in females (56%) compared to males 
(44%). Statistically gender was not associated with non-compliance to TB 
treatment (P=0.636). A study conducted by Kaona, Tuba, Siziya and Sikaona 
(2004:68) in Zambia and another study by Erhabor et at. (2000:235) in Nigeria 
got similar findings that gender is not statistically associated with non-compliance 
to TB treatment. 
5.4 MARITAL STATUS OF RESPONDENTS 
In this study, compliance was higher amongst single participants (47%) 
compared to those who are married (18%) and participants who are divorced, 
separated or widowed (22%). Marital status was also not statistically associated 
with non-compliance to TB treatment (P=0.506). This finding was consistent with 
the study conducted in Zambia by Kaona, Tuba, Siziya and Sikaona (2004:68) in 
which marital status was also not associated with non-compliance to TB 
treatment. 
5.5 RESPONDENTS' RACE 
Black participants were more compliant (73%) compared to coloured participants 
(3%). Statistically race was not associated with non-compliance to TB treatment 
(P=0.112). Studies conducted in South Africa in the past regarding non-
compliance to TB treatment have not investigated whether race is associated 
with non-compliance to TB treatment. 
5.6 EDUCATIONAL STATUS OF RESPONDENTS 
Respondents who had secondary level education were most compliant (31%) 
compared to participants with no schooling (14%). Statistically educational level 
was not associated with non-compliance to TB treatment (P=0.186). This is 
contradictory to findings from a study by Gad eta/. (1997:244-250) in which low 
educational levels were associated with non-compliance to TB treatment. 
5.7 EMPLOYMENT STATUS OF RESPONDENTS 
Respondents who were unemployed were most compliant to TB treatment (56%) 
compared to self-employed respondents (12%). There was no statistical 
association between employment status and non-compliance to TB treatment 
(P=0.670). This is different from findings in a study conducted by Mishra et a/. 
(2005: 1134-1139) in Nepal in which non-compliance to TB treatment was 
significantly associated with unemployment. 
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5.8 PARTICIPANTS' REASONS FOR MISSING A DOSE (S) OF THEIR TB 
TREATMENT 
Length of treatment: The most common reason cited by 29% of the patients for 
missing TB treatment was the extended period (6-8 months) for completing the 
recommended TB treatment. 
Pill burden: According to 18% of the respondents, the pill burden was the reason 
for missing TB treatment; as many as 5 tablets are normally ingested by a TB 
patient on a daily basis. This number increases for patients who are taking other 
medications for chronic illnesses such as HIV. 
Distance to the clinic/facility of treatment: 13% indicated that the long distance to 
the clinic was the reason for poor compliance to TB treatment. This finding is 
similar to a report from a study by Malik & Ahmad (2009:70-75) which reported 
that 93% of the non-compliant TB patients had a long distance to travel before 
accessing care (n=1 00). In the current study, the most non-compliant participants 
were residing more than 20km from the TB control clinic (30%). 
Only 5% of the local residents were non-compliant to TB treatment; indicating 
that there were other deterrents to compliance to TB treatment than the distance 
from the health care facility. 
Negative attitudes of health care providers: 19% of the respondents revealed that 
negative attitudes of health care workers were a deterrent to accessing TB 
treatment; hence they were non-compliant to the treatment. 
Alternate method of care: 11% of the participants indicated that they had missed 
a dose of their TB treatment because they were using traditional medicines which 
were perceived to be a complimentary drug to treat TB. 
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Non availability of food: about 10% of the respondents were of the opinion that 
food played a pivotal role in complementing TB drugs; when there was food 
shortage they failed to comply with TB treatment. These reasons should be 
considered seriously since they were reported by the patients and must be 
addressed appropriately in order to improve compliance to TB treatment. 
5.9 ASSESSING THE LEVEL OF TB TREATMENT KNOWLEDGE AMONG 
PULMONARY TB PATIENTS 
5.9. 1 Do you believe that you are suffering from TB? 
Patient knowledge about the disease and its treatment enhance treatment 
compliance to treatment (Mainga 2008:87). Compliance was higher in 
participants (87%) who believed they were suffering from TB compared to 
participants who did not believe (11 %). Not believing that you are suffering from 
TB was not statistically associated with non-compliance to TB treatment 
(P=0.503). This was similar to findings by Motlhanke (2005:65) in a qualitative 
study conducted in Limpopo which found that 'denial' or not believing that you 
are suffering from TB is not associated with non-compliance to TB treatment. 
5.9.2 Do you believe that the TB diagnostic method used was accurate? 
Compliance was higher in patients who believed that the TB diagnostic method 
used is accurate (81 %) compared to patients who did not believe (19%). Not 
believing that the TB diagnostic method used was accurate was not associated 
with non-compliance to TB treatment (P=0.684). A study by Tshabalala (2007:84) 
conducted in Tembisa also found that patient's perceptions about the disease 
and its diagnosis is not associated with non-compliance to TB treatment. 
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5.9.3 TB can result to death if not treated 
Compliance was higher among patients who knew that TB can result in death if 
not treated (98%) compared to patients who were not aware that TB can result to 
death if not treated (2%). Not believing that TB can result to death if not treated 
was statistically associated with non-compliance to TB treatment (P=0.04). A 
study by Gad et al (1997:244-250) also confirmed that lack of patients knowledge 
about TB treatment was associated with non- compliance to TB treatment. 
5.9.4 TB can be cured if treatment is taken daily for the correct duration 
Compliance was higher (97%) among patients who knew that TB can be cured if 
TB treatment is taken daily for the correct treatment duration, compared to 
patients who did not know (36%). Not believing that TB can be cured if treatment 
is taken daily for the correct treatment duration was not associated with non-
compliance to TB treatment (P=0.451). This is in line with findings from a study 
by Ghani (201 0:87) in Namibia, which stated that patients who did not believe 
that TB treatment should be taken for the correct duration were likely to be non-
compliant to TB treatment. 
5.9.5 Patients' knowledge on why it is important to take TB treatment for the 
prescribed duration 
Compliance was higher amongst patients who indicated that it is important to 
take TB treatment for the prescribed duration in order to be cured (98%) 
compared to those who reported that is important to take TB treatment for the 
prescribed duration to prevent drug resistance (80%). This factor was not 
statistically associated with non-compliance to TB treatment (P=0.289). 
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5.10 FACTORS CONTRIBUTING TO NON-COMPLIANCE TO TB TREATMENT 
TB treatment non-compliance is recognised as one of the major challenges in 
achieving TB control (Ghani 2010: 84). Factors contributing to non-compliance to 
TB treatment discussed in this study include client related, health service related, 
sociocultural as well as disease and medicine related factors. 
5. 10. 1 Client-related factors 
Non-availability of food whilst taking TB treatment was associated with non-
compliance to TB treatment (P=0.01). This is in line with findings from a study 
conducted by Ghani (201 0:85) in which he states that non-availability of food for 
patients on TB treatment contributes to non-compliance to treatment. Another 
client-related factor associated with non-compliance to TB treatment in this study 
was not believing that TB can result in death if left untreated (P=0.04). This is 
consistent with findings from a study conducted by Mainga (2008:81), which 
states that patients' lack of understanding of TB treatment is associated with non-
compliance to treatment. 
5. 10.2 Health service related factors 
Health care worker attitudes and accessibility issues (distance and cost of getting 
to the health facility) have been shown in other studies to be important factors 
affecting TB treatment compliance (Ghani 201 0:84). This is because health 
worker attitudes, such as being unfriendly to patients, tend to deter patients from 
seeking treatment or coming to collect medicines once they are finished (Ghani 
2012:84). In this study, negative attitudes of health care workers were associated 
with non-compliance to TB treatment (P=0.021). This is consistent with findings 
from the study conducted by Malik & Ahmad (2009:70-75) which found that 
health care worker attitudes in the clinic where patients receive their TB 
treatment is associated with non-compliance to TB treatment. 
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Distance travelled by TB patients to the clinic for treatment was associated with 
non-compliance to TB treatment (P=0.015). This is in line with other studies 
which also found that the further the clinic was from the patient the greater the 
probability that the patient would be non-compliant to TB treatment (Bam et a!., 
2005:54; Jaiswal eta!., 2003:625). 
5.10.3 Disease and medicine-related factors 
Reasons that were significantly associated with non-compliance to TB treatment 
in this study were that TB treatment takes very long to complete (P=O.OOO) and 
the pill burden or too many pills to take (P=0.023). This is in line with findings 
from a study conducted by Motlhanke (2005:70) which found that patients who 
believed that TB treatment takes very long were more likely to be non-compliant 
to treatment because they reported that they get tired of the treatment and end 
up not taking it as prescribed. 
5. 10.4 Socio-cultural factors 
Socio-cultural factors will cover patients' beliefs in traditional medicines and 
components of the health belief model. Belief in traditional medicine for curing TB 
was associated with non-compliance to TB treatment (P=0.025). This is 
consistent with findings from other studies conducted in South Africa which state 
that patients beliefs and use of traditional medicine during TB treatment are 
associated with non-compliance to treatment (Tshabalala, 2007:85; Motlhanke, 
2005:70). 
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5.10.5 Health belief model components 
Concepts of the health belief model that were used as a theoretical foundation for 
the study were: perceived susceptibility; perceived benefits of action; and 
perceived barriers to action. This study has shown that respondents who were 
knowledgeable on the perceived benefits of action were more compliant to TB 
treatment, that is, knowledge about the importance of taking TB treatment for the 
prescribed duration in order for the patient to be cured. 
Factors related to perceived barriers to action which were significantly associated 
with non-compliance to TB treatment in this study are: TB treatment takes very 
long to complete; and the pill burden. Factors related to perceived susceptibility 
were not associated with non-compliance to TB treatment in this study. 
5.11 WHAT COULD MAKE PATIENTS COMPLETE THEIR TB TREATMENT? 
There were several responses from the patients when they were asked their 
opinion on what could be done to help TB patients increase their compliance to 
TB treatment. One hundred and sixteen participants responded to this question 
and 96 did not respond. Twenty three (20%) of the respondents wanted support 
from family members followed by twenty one (18%) who stated that healthcare 
workers attitudes towards TB patients should change. Eighteen (16%) wanted 
ongoing education on the dangers of not completing TB treatment whilst 
seventeen (15%) indicated that TB clinics should be opened on weekends for 
patients to refill their TB drugs. 
Thirteen (11 %) wanted food parcels for TB patients whilst twelve (1 0%) indicated 
that they wanted proper treatment of side effects to make them complete their TB 
treatment. Other responses were that TB patients should have a drug holiday on 
weekends and TB patients should not be discriminated against. 
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The patient responses reinforced the need to bargain for family support, provide 
ongoing education to TB patients and change in healthcare worker attitudes. It 
was also interesting to note that patients feel that side effects should be treated 
or managed better. 
5.12 CONCLUSIONS 
Non- compliance to TB treatment amongst pulmonary TB patients in Waterberg 
District, Limpopo, South Africa is associated with non-availability of food whilst 
taking TB treatment, not believing that TB can result in death if not treated, 
beliefs in traditional medicines for curing TB, bad health-care worker attitudes, 
long distance to the clinic/facility of treatment, feeling that TB treatment takes too 
long and the pill burden (too many pills to take daily). 
5.13 RECOMMENDATIONS 
Based on the findings, the researcher makes the following recommendations for 
practice and future research. 
5.13.1 Practice 
In order to prevent non-compliance to TB treatment in Waterberg district, 
Limpopo, South Africa and elsewhere, the researcher recommends that: 
• Health education should be intensified within the communities, focusing on 
all the TB patients be intensified, particularly at the beginning of treatment, 
with reinforcement at each visit using the local language. This 
intensification should be comprehensive to include duration of treatment, 
possible side effects and how to deal with them, consequences of not 
completing TB treatment and the dangers of using traditional medicines 
during TB treatment. 
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o Traditional health practitioners should be educated on TB and be involved 
in TB control through private-public partnerships and by motivating them 
not to mislead the community by claiming that they can cure TB. 
o The Direct Observation of Treatment (DOT) should be strengthened to 
ensure that all pulmonary TB patients are observed and supported 
throughout the treatment duration. 
o Income-generating activities should be initiated to improve food provision 
for patients on TB treatment. Also TB patients should be linked to social 
services and community programmes that provide food. 
o To improve healthcare worker attitudes, workers should be trained in 
customer care and care of carers programmes should be available for 
them to de-stress and cope better with the increasing number of TB 
patients seen on a daily basis. 
o Nurses in mobile teams should be trained on Basic TB management to 
enable them to refill TB drugs for patients as part of their outreach 
services. 
5.13.2 Recommendations for further research studies 
o This study should be repeated involving a larger sample and comparing 
districts in order to identify similarities and differences in the factors which 
contributes to non-compliance to TB treatment. 
o Further research is needed to identify and compare non-compliance to TB 
treatment for men and women in Waterberg District. 
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• A qualitative study on the reasons for non-compliance in the same district, 
should be conducted with respondents describing their lived experience as 
TB patients. 
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Annexure 1: Questionnaire 
Individual patient's questionnaire number: L[J 
Date of interview ___________ _ 
Instructions: Please tick in the appropriate box 
SECTION A: DEMOGRAPHIC INFORMATION 
D D 
A.1 Age in years: (18-25) ........ 1. (26-33) ..... 2 (34-41) ..... 3 
(42-49) ........ .40 (50-55) ......... 50 (58-65) ....... 6 0 (66-73) .......... 0 (>73) ...... 8CJ 
A.2 Gender: Male ....... 10 Female ........ 0 
A.3 Marital status 
Single .................................... 1 D 
Married ................................... 2 D 
Living with partner. ................... 3 D 
Divorced/separated/widowed ..... .4 0 
A.4 Race 
Black ....................................................... 1 
White ...................................................... 2 
Coloured .................................................. 3 
lndian ..................................................... .4 
A.5 What is your highest level of education? 
No school. ................................. 1 
Primary ..................................... 2 
Secondary ................................. 3 
Matric ...................................... .4 
Tertiary ...................................... 5 
A.6 Religion: 
christian ........... 1D Muslim .......... 2D other. ...... 3D 
SECTION 8: SOCIO-ECONOMIC VARIABLES 
8.1 Employme~t~~~~~::d .................................... 
18 Unemployed ............................... 2 
Self employed ............................. 3 
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8.2 What is your income per month? 
None ........................................ 1 
R <1000 ..................................... . 
R1 000-2000 ................................ 3 
R >2000 ................................... 4 
8.3 Availability of food whilst taking T8 treatment: 
Always available to take with medicines ...... 1 0 Not always available ............. 2 0 
Never available ...................................... 30 
SECTION C: CLIENT-RELATED FACTORS 
D 
C.1 Do you believe that you are suffering from T8? Yes ..... O No ......... 2 
C.2 Do you think that the T8 diagnostic method used is accurate? Yes .. O No ... Q 
C.3 T8 can result in death if not treated Yes ..... 1 0 No ....... O 
C.4 T8 can be cured if T8 treatment is taken daily for the correct treatment duration (6-8 
months) Yes ... 10 No .... 20 
C.5 Why is it important to take T8 treatment for the prescribed duration (6-8 months)? (Tick 
all that applies) 
To prevent drug resistant T8 Yes ... 10 No ... 20 
To be cured Yes .... Q No .... 2D 
To prevent the spread of T8 Yes ..... 10 No .... 2 D 
To prevent death Yes ..... 10 No ...... 20 
Other (specify) ........................................................................................... . 
C.6 Are you currently receiving the disability grant? Yes ....... 1 0 No ... 2 0 
C. 7 Are you receiving any food package? Yes ....... 1D No ... 2D 
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SECTION D: HEALTH SYSTEM RELATED FACTORS 
0.1 How are the health care workers' attitudes in the clinic/facility of treatment? (Tick all 
that applies) 
Friendly 
Caring 
Rude 
Uncaring 
Yes ...... 1 D 
Yes ...... 1§ 
Yes ........ 1 
Yes ....... 1 
No ........ 20 
No ....... 2EJ 
No ....... 2 
No ......... 20 
0.2 How much time do you spend in the clinic/facility for monthly refill of TB treatment? 
<1 hour ........................................................... 1 B 
2-3 hours ......................................................... 2 
>3 hours ......................................................... 3 
0.3 How much distance do you travel to collect your TB medicines (Km)? 
(<5) ..... 10 (5-10) ..... 2 D (11-15) ...... 3 0 (>15) ....... .4 D 
0.4 Do the operating times for the clinic/facility make it easy for you to receive treatment 
any time you need it? Yes ..... 1 0 No .... 20 
0.5 How much does it cost for you to reach the clinic/facility from home (Rands)? 
<R10 ..... 1 D R10-R50 .............. 2D >R50 ................... 3D 
SECTION E: SOCIO-CULTURAL BARRIERS 
E.1 TB can be cured by using traditional medicines? Yes ..... 1D No .... 2D 
SECTION F: DISEASE AND MEDICINE-RELATED BARRIERS 
F.1 What are the reasons for not completing TB treatment? (Tick all that applies) 
Treatment takes very long to complete Yes ... 1 No ... 2 
Side effects of anti-TB drugs 
Too many pills to take daily 
TB can still be cured even if treatment is not completed No ... 2 
Other (specify) ..................................................................................... . 
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F.2 Have you ever missed your dose(s) of TB drugs before? Yes ... 10 No ...... {] 
F.3 If yes, what was the reason (s) for missing your TB drugs? 
F.4 In your opinion, what could make patients complete their TB treatment? 
Thank you for your time and cooperation. 
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Annexure 2: Patient consent form 
STUDY TITLE: FACTORS CONTRIBUTING TO NON-COMPLIANCE TO 
PULMONARY TUBERCULOSIS TREATMENT AMONG PATIENTS IN 
WATERBERG DISTRICT LIMPOPO PROVINCE 
Investigator: Cindy Dladla 
Dear Sir/ Madam, 
I am conducting a study to identify factors contributing to patients not taking their 
TB medicines correctly. The findings of the study will be used to improve TB 
patient care management and thus reduce further spread of TB in the 
community. The study and its procedures have been approved by the Limpopo 
Department of Health as well as the Unisa ethics committee. A trained 
interviewer will administer a questionnaire in order to collect data and it should 
take about 30 minutes to complete. 
There are no foreseeable risks associated with the interview and you can contact 
me on the following cell phone number, 079 601 8467 if you have any further 
questions after the interview. Your participation in this study is voluntary. I 
therefore request you to assist with answering the questions included in this 
questionnaire. Please note that any information which may identify you will be 
kept strictly confidential and your responses will in no way lead to any adverse 
effect on you and no medical care will be withheld from you because of the 
responses you may provide. 
If you agree to this interview, you may sign below but if you do not agree, you 
can let me know at this point and I will not proceed with the interview. 
Signature/ Thumb print of respondent.. ..................................................... . 
Date ............................................................................... . 
101 
Annexure 3: Request for permission to conduct research from Limpopo 
Department of Health 
Limpopo Department of Health 
Polokwane 
Dear Sir/Madam 
5 San Antonio 
V aalboom road 
Glen Marais, Kempton Park 
16'h March 2012 
RE: REQUEST TO CONDUCT A STUDY ON FACTORS CONTRIBUTING TO 
NON COMPLIANCE TO TB TREATMENT AMONGST PULMONARY TB 
PATIENTS IN W ATERBERG DISTRICT IN FULFILLMENT OF THE 
REQUIREMENTS FOR THE MASTER OF PUBLIC HEALTH DEGREE 
I would like to request for permission to conduct the above mentioned study in Waterberg 
district in fulfillment of the requirements for the Master of Public Health degree which I 
am currently doing with the University of South Africa (UNISA). 
Attached is the study protocol which has been approved by the UNISA health studies 
research and ethics committee. 
Your consideration of this request will be highly appreciated. 
Kind regards 
difltdk 
Cindy. N. Dladla 
079 601 8467 
cindydladla@ gmail.com 
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LIMPOPO 
PROVINCIAL GOVERNMENT 
REPUBLIC OF SOUTH AFRICA 
DEPARTMENT OF HEALTH 
Enquiries: Selamolela Donald Ref:4/2/2 
Dladla CN 
UN ISA 
Pretoria 
0001 
. 
.... 
Greetings, 
Re: Permission to conduct the study titled: Factors contributing to non compliance to 
pulmonary tuberculosis treatment among patients in Waterberg District Limpopo Province. 
1. The above matter refers. 
2. Permission to conduct the above mentioned study is hereby granted. 
3. Kindly be informed that:-
• Further arrangement should be made with the targeted institutions. 
• In the course of your study there should be no action that disrupts the services. 
• After completion of the study, a copy should be submitted to the Department to serve 
as a resource. 
• The researcher should be prepared to assist in the interpretation and implementation 
of the study recommendation where possible. 
Your cooperation will be highly appreciated. 
Head Department Date 
18 College Street, Polokwane, 0700, Private Bag x9302, POLOLKWANE, 0700 
Tel: (015) 293 6000, Fax: (015) 293 6211/20 Website: http/www.limpopo.gov.za 
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